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Abstract  
 
Arkbåge, K. 2003. Vitamin B12, folate and folate-binding proteins in dairy products – 
analysis, process retention and bioavailability. Doctoral dissertation. 
ISSN 1401-6249, ISBN 91-5766470-6   
 
Vitamin B12 and folate are two important B vitamins for maintaining good health, being 
involved in amino acid metabolism and DNA synthesis. Milk and dairy products are good 
sources of vitamin B12 and folate. Moreover, they are of interest due to their content of 
folate-binding proteins (FBP), since it was hypothesised that these promote folate 
bioavailability. Furthermore, fermentation of milk is a way to increase the content of both 
vitamins.  
 
Vitamin analysis in fermented dairy products is complicated due to the complex matrix. To 
gain reliable data on vitamin content, retention and bioavailability, emphasis throughout the 
project was put on optimisation and evaluation of methods for quantification. A commercial 
radio protein-binding assay (RPBA), produced for clinical samples, was evaluated 
regarding, e.g. assay pH, buffer molarity and food matrix effects. The optimised RPBA was 
demonstrated to be suitable for quantification of vitamin B12 in milk and fermented dairy 
products, and of folate quantification in dairy samples containing mainly 5-methyl-
tetrahydrofolate. 
 
One aim of this project was to map the retention of vitamin B12 and folate during 
manufacture of six fermented dairy products. Results showed, e.g. that fermentation of milk 
followed by storage at 4 °C for 14 days decreased vitamin B12 concentrations in fermented 
milk by 40-60% compared with concentration in the milk. However, vitamin B12 was 4-7-
fold concentrated during hard cheese making. Regarding folate, the concentrations of folate 
increased both during fermentation of milk to yoghurt and during manufacture of cheese.  
 
Another aim was to study folate bioavailability from milk and fermented milks using both 
an in vitro gastrointestinal and a human model. Focus was on studying the stability and the 
nutritional role of bovine milk FBP, which are suggested to have a positive impact on folate 
bioavailability. Both studies showed FBP to partly endure in vitro and in vivo 
gastrointestinal passage, and further, to decrease in vitro and in vivo folate bioavailability. 
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methyltetrahydrofolate, folate bioavailability 
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Sammanfattning 
 
Folater och vitamin B12 är två viktiga B-vitaminer som bl.a. levererar byggstenar 
för uppbyggnad av kroppens arvsmassa (DNA) och är därför mycket viktiga vid 
tillstånd av kraftig cellnybildning som t.ex. vid graviditet. Folater har också rönt 
stor uppmärksamhet de senaste decenniet för sin förmåga att förhindra 
missbildningar och missfall under tidig graviditet. Båda vitaminerna krävs också i 
aminosyrametabolismen, för omvandlingen av homocystein till metionin. Höga 
halter av homocystein i blodet har både visat sig vara en riskfaktor för att drabbas 
av hjärt- och kärlsjukdom, och har också påvisats ha en negativ påverkan på 
minnesfunktioner genom att bl.a. ge en ökad risk för vissa demenssjukdomar som 
t.ex. Alzheimers sjukdom.   
 
Olikt många andra vitaminer som syntetiseras i växter så produceras vitamin B12 
endast av mikroorganismer, och återfinns därför nästan exklusivt i livsmedel med 
animaliskt ursprung. En speciellt rik kostkälla för vitamin B12 är lever, andra goda 
källor är t.ex. kött, fisk, ägg, mjölk, yoghurt och ost. I motsats till vitamin B12 
återfinns folater i flera livsmedelsgrupper. Rika folatkällor är inälvsmat, 
bladgrönsaker, vissa frukter och bär, spannmålsprodukter samt vissa ostar. I vår 
svenska kost står mjölk- och mejeriprodukter för 22% av vårt vitamin B12-intag 
och för 15% av folatintaget. 
 
Det är svårt att ta fram tillförlitliga värden för vitamin B12- och folathalter i 
livsmedel p.g.a. naturligt förekommande låga koncentrationer, förekomst av många 
olika vitaminformer med varierande stabilitet, samt att livsmedelsmatrisen i sig 
eventuellt kan leda till att vitaminkoncentrationerna över- eller underskattas. 
Utöver ett behov av framtagande av validerade analysmetoder för 
vitaminbestämning för att kritiskt kunna utvärdera hur olika betingelser under t.ex. 
process, odling och lagring påverkar vitamininnehållet i den mat vi äter, behöver vi 
också veta hur mycket av de vitaminer vi får i oss som kroppen verkligen kan 
tillgodogöra sig. Denna information tas fram med hjälp av 
biotillgänglighetsstudier. Befintliga data på biotillgänglighet av vitaminerna är ofta 
knapphändiga och framtagna med bristfällig metodik. 
 
För att kunna ta fram tillförlitliga data på vitaminretention samt information om 
biotillgänglighet har en kommersiell radio-protein-bindar-metod (RPBA), från 
början framtagen för analys av kliniska prover, anpassats för analys av vitamin B12 
och folater i mjölk- och mejeriprodukter. Efter omfattade optimerings- och 
utvärderingsarbete innefattande en noggrann kartläggning av hur olika faktorer 
såsom pH, jonstyrka på buffertlösningar, samt hur användandet av externa 
standardsubstanser påverkar analysresultatet, är metoden nu tillförlitlig för vitamin 
B12-analys i mjölk- och fermenterade mejeriprodukter, samt för folatanalys i mjölk. 
Även övriga använda metoder för analys av FBP och biotillgängligheten har 
bearbetats för att uppnå större kvalitetssäkring. 
 
Ett av syftena i detta forskningsprojekt har varit att kartlägga vitaminretentionen 
under framställning av utvalda fermenterade mejeriprodukter, att från mjölk till 
färdig produkt följa vad som händer med vitaminhalterna. Resultaten från studien 
visade t.ex. att fermentering av mjölk till yoghurt och filmjölk, samt efterföljande  
lagring i kylskåp i 14 dagar (till bäst före-datumet) sänkte vitamin B12-halterna med 
40-60% jämfört med koncentrationerna i ursprungsmjölken. En betydelsefull faktor 
för vitamin B12-halterna i fermenterade produkter som yoghurt och filmjölk är 
mjölksyrabakteriernas förmåga att antingen producera eller konsumera vitamin B12.  
Jämför man koncentrationerna av vitamin B12 i ost med den i mjölk, har vitaminet 
koncentrerats 5-8 gånger i osten. För att framställa 1 kg ost åtgår ca 10 liter mjölk. 
Koncentrationen av folat var högre i både yoghurt, filmjölk och ost jämfört med 
folatkoncentrationen i mjölk. En stor andel av båda vitaminerna förloras vid 
avskiljning av vasslen från ostmassan under osttillverkning. Dessa förluster kan 
dock i vissa fall kompenseras genom mikrobiell syntes av vitaminerna under ostens 
mognad.  
 
Vidare har biotillgängligheten av folater från mjölk, yoghurt och filmjölk 
undersökts i en humanmodell samt i en datorstyrd simulerad magtarm-modell. 
Fokus har legat på att studera i mjölk befintliga folat-bindande proteiners (FBP) 
påverkan på biotillgängligheten av folat. FBP har i några studier visat sig öka 
upptaget av kostens folat, och dess näringsfysiologiska roll har länge diskuterats. 
Resultat från detta projekt har bidragit med ny kunskap vad gäller FBPs effekter på 
biotillgängligheten av folat. Både studien på människa och studierna i den 
simulerade magtarm-modellen visade att FBP delvis ”överlever” magtarm-
passagen utan att brytas ner av matsmältningsenzymer, samt att proteinet påverkar 
upptaget av folat i tarmen negativt, dvs sänker biotillgängligheten av folat. 
Effekten är större för folsyra, folatformen som används för berikningsändamål, än 
för den naturligt dominerande folatformen. FBP överlever pastörisering och finns i 
vår konsumtionsmjölk. Däremot finns den inte i yoghurt och filmjölk som 
värmebehandlas vid högre temperaturer. Den något bättre folatbiotillgängligheten 
hos yoghurt och filmjölk jämfört med mjölk kan därför förklaras av att yoghurt inte 
innehåller FBP. Våra studier har även visat att såväl mjölk som yoghurt och 
filmjölk är lämpliga livsmedel för berikning med folat. För modersmjölks-
ersättningar och vällingar, som ofta berikas med folsyra, bör man se till att 
produkterna inte innehåller aktiv FBP. En annan roll som tillskrivits FBP är dess 
stabiliserande inverkan på folat under processning och lagring och kanske också i 
samband med passagen genom mag-tarmkanalen. Det förstnämnda har vi inte 
studerat, och  någon positiv stabiliseringseffekt i mag-tarmkanalen kunde vi inte 
belägga. Däremot fann vi att FBP bildade ett stabilt komplex med den syntetiska 
folatformen, vilket ledde till en minskad biotillgänglighet.  
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Introduction 
 
In the post-industrial society every second person will develop folate and vitamin 
B12 deficiency during the last ten years of life (Hultdin, 2003). A combined 
deficiency of these two vitamins is associated with neuropsychiatric disorders 
among elderly, e.g. development of dementia and Alzheimer’s disease (Seshadri et 
al., 2002). Moreover, deficiency of vitamin B12, folate or vitamin B6 is associated 
with elevated plasma homocysteine levels, a risk factor for cardiovascular diseases, 
the leading cause of mortality in most Western countries (Brattström et al., 1984, 
Boushey et al., 1995, Jacobsen, 1998). Apart from the prevention of cardiovascular 
diseases, several studies during the last decade focus on the protective role of 
folate against neural tube defects during early pregnancy (Daly et al., 1995, Berry 
et al., 1999, Molloy, 2002). Furthermore, there is growing evidence that a low 
folate status is linked to an increased cancer risk, particularly colon cancer 
(Giovannucci et al., 1995).  
Taken together these health protective effects of folate and vitamin B12 point to a 
need to update and critically evaluate different foods for their potential as good 
sources of both these vitamins. In this perspective milk and fermented dairy 
products are interesting since they provide 15% of the daily intake of folate and 
22% of vitamin B12 in the Swedish population (Livsmedelsverket, 2002).  
 
Dairy products constitute a difficult food matrix for analyses of these vitamins. 
Still today, there is little reliable information about actual concentrations of vitamin 
B12 and folate in food, and about which impact food processing techniques have on 
vitamin retention. This is often due to use of unspecific analytical methods and 
insufficient methodological control. There is also a need for optimisation of 
samples preparation prior to analysis, which differs from one food item to another. 
Another important issue regarding critical evaluation of the dietary folate concerns 
the bioavailability, which has been estimated to range between 40-70%, based on 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Linkage of folate and vitamin B12 in the cell metabolism.  
With kind permission from Lökk, Scandinavian Journal of Nutrition, 2003.  12
relatively few studies (for review see Bates & Heseker, 1994). Again, many of 
these studies are performed by methodology, which is today questioned. 
 
In this thesis, efforts have therefore focussed on improved quality assurance of 
analytical methods, which thereafter are used to map the retention of the vitamins 
in typical fermented dairy products. Major emphasis is put to clarify the role, if 
any, of folate-binding proteins on the absorption of folate from dairy products.  
The literature review following this section will begin with a brief summary on 
nutritional aspects of these vitamins. Thereafter the state-of-the-art concerning 
chemistry, analyses, occurrence and bioavailability of folate, folate-binding 
proteins and vitamin B12 are given, forming the base for the objectives and the 
summary of the experimental work. The last part of the thesis contains the five 
original papers comprising the experimental work, i.e. the new knowledge that 
came out of this project.   13
Literature review 
 
Nutritional aspects  
Vitamin B12 (cobalamin) 
Two vitamin B12-dependent enzymes are recognized in humans. Methylcobalamin 
acts as coenzyme in methionine synthetase involved in conversion of homocysteine 
to methionine, involving also folate. The other enzyme is methylmalonyl-CoA 
mutase, which requires deoxyadenosylcobalamin during conversion of 
methylmalonyl-CoA to succinyl-CoA in the propionate catabolism. Inadequate 
intake is usually not the cause of vitamin B12 deficiency, but instead malabsorption 
due to atrophy of the gastric mucosa resulting in deficient intrinsic factor (IF) 
production, or disease located to the terminal ileum where the vitamin is absorbed. 
Deficiency results in two types of clinical symptoms, anaemia and neurological 
dysfunction. As reviewed by Truswell & Milne (2002), the neurological symptoms 
are suggested to depend on accumulation of propionate due to lowered activity of 
methylmalonyl-CoA mutase, whereas anaemia is caused by a secondary folate 
deficiency, since a lack of vitamin B12 results in that folate is trapped as 5-
methyltetrahydrofolate, and thereby a depletion of 5,10-methenyltetrahydrofolate 
needed for pyrimidine (DNA) synthesis occurs.   
 
The recommended daily intake of vitamin B12 for adults is set to 2 µg/d for the 
Nordic countries (Sandström et al., 1996). In general, the population meet the 
recommended dietary intake by an ordinary mixed diet (Livsmedelsverket, 2002). 
However, certain groups, e.g. strict vegetarians (vegans) and elderly might suffer 
from inadequate vitamin B12 levels (Herbert, 1996, Scott, 1999). Vitamin B12 is 
exclusively produced by microorganisms and therefore higher plants lack vitamin 
B12 unless processed microbiologically. Good vitamin B12 food sources are e.g. 
liver, fish, meat, eggs, and dairy products. From only one glass of milk 40% of the 
recommended daily intake of vitamin B12 is provided. 
 
Folate 
The native forms of folate are tetrahydrofolate compounds. They play an essential 
role in the transfer of one-carbon units in the body. The folate derivative involved 
as carbon donor in purine and pyrimidine synthesis (RNA and DNA) is 5,10-
methylenetetrahydrofolate, whereas 5-methyltetrahydrofolate co-operates with 
vitamin B12 in the action of methionine synthetase, which converts homocysteine to 
methionine (Truswell & Milne, 2002). Folate deficiency results in impaired cell 
division due to reduced purine and pyrimidine synthesis, resulting in megaloblastic 
anaemia (Scott, 1999). Folate deficiency is developed in the presence of 
malnutrition, due to low intake of folate-containing foods, or as a result of 
alcoholism. Another risk factor is malabsorption, especially for diseases affecting 
either gastric pH or the jejunal mucosa, e.g. celiac disease.  
 
Previous recommendations concerning intakes of essential nutrients aimed to 
cover the needs of the consumer in order to prevent deficiency diseases. Recent 
knowledge has raised the question of whether recommendations should also  14
consider the potential that a nutrient might be important to reduce the risk of 
chronic disease among the middle-aged and elderly (Bailey, 1995, Bailey, 1998). 
In the latest edition of the Nordic Nutritional Recommendations (1996), the daily 
folate intake for adults was increased from 200 µg to 300 µg folate and for 
pregnant women a daily intake of 400 µg was recommended (Sandström et al., 
1996). When publishing the dietary reference intakes (DRI) in 1998, the US Food 
and Nutrition Board included the concept of possible health-protective effects of 
folate by increasing recommendations for adults to 400 µg/d from previously 200 
µg/d (Yates et al., 1998). Moreover, US Food and Nutrition Board recommends 
women who plan a pregnancy to consume an additional 400 µg synthetic folic acid 
from fortified foods or supplements. Folate is found in a variety of food products, 
especially vegetables, fruits, berries and cereals (reviewed by Witthöft et al., 
1999). On average, milk and dairy products provide 10-15% of the daily folate 
intake in many Western countries. 
 
Nomenclature, chemical structure and stability  
Vitamin B12 
The term ‘vitamin B12’ has two meanings. To the chemist, it means only 
cyanocobalamin, whereas in nutrition and pharmacology literature, vitamin B12 is a 
generic term for all corrinoids exerting biological activity in humans. In the 
following text the nutritional definition of vitamin B12 is used (Herbert, 1996). 
Cobalamins have a complex chemical structure based on a corrin ring system with 
a cobalt ion in the centre (Fig. 2). All the compounds containing this ring are 
designated corrinoids. The sixth position of the cobalt may be occupied by 
different anionic substituents, (-R). This substituent is generally one of the 
following: CN- (cyanocobalamin), -OH (hydroxocobalamin), H2O- 
(aquacobalamin), -NO2 (nitritocobalamin), -SO3 (sulphitocobalamin), -CH3 
(methylcobalamin), or -5´-deoxyadenosyl (adenosylcobalamin). Cobalamins by 
definition resemble this molecular structure excluding the R-group, presented in 
Fig. 2. 
 
Cyanocobalamin, the synthetic and most stable form of the vitamin, is not found 
in any significant amounts in nature but is an artefact from isolation procedures. 
This synthetic derivative of vitamin B12 and hydroxocobalamin are available for 
medical use, food fortification purposes, and nutrient supplements. The cyanide 
group of cyanocobalamin can be replaced by other ions. These reactions have little 
influence on the net vitamin B12 activity of foods since most cobalamin derivatives 
exhibit biological activity in humans. These interconversions are, however, 
important to consider during analysis of vitamin B12 (for details see the section 
Methods of quantification below). The mechanism of vitamin B12 degradation has 
not been fully explained, in part because of the complexity of the molecule and the 
low concentrations found in foods. Both acidic hydrolysis, exposure to alkaline 
conditions and reducing agents, such as ascorbic acid, are reported to induce 
fragmentation of the vitamin molecule (Herbert, 1996, Eitenmiller & Landen, 
1999b).  
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Folate 
Folate refers to the large group of heterocyclic compounds based on the pteroic 
acid structure conjugated with one or more L-glutamates linked through the γ-
carboxyl group of the amino acid. The generic term “folate” refers to the class of 
compounds having a chemical structure and nutritional activity similar to that of 
folic acid (pteroyl-L-glutamic acid) (Blakley, 1988). In nature, the vitamin exists 
primarily as reduced one-carbon-substituted pteroylglutamates, varying in the 
presence of substituents and the number of glutamyl residues attached to the 
pteroyl group (Fig. 3). Five different one-carbon units can be linked at the N
5- 
and/or N
10-position of the pteroyl group: CH3- (5-methyltetrahydrofolate), HCO- 
(5- or 10-formyltetrahydrofolate), CHNH- (5-formiminotetrahydrofolate), -CH2- 
(5,10-methylenetetrahydrofolate), or –CH= (5,10-methenyltetrahydrofolate). One 
of the reduced folate derivatives exists without substituent and is called 
tetrahydrofolate (H4folate). All together the theoretical number of all native folate 
compounds reaches several hundreds (Eitenmiller & Landen, 1999a). 
Interconversion of derivatives due to, e.g. pH shifts is reported. Synthesis of 5-
HCO-H4folate from H2folate, and enzymatic interconversion of 5-HCO-H4folate to 
other tetrahydrofolate derivatives are described (Stover & Schirch, 1991, Ndaw et 
al., 2001). 
 
There are considerable differences in the stability of reduced folate compounds. 
In most cases, folic acid exhibits substantially greater stability than reduced forms. 
The order of stability of these latter forms in water is: 5-HCO-H4folate > 5-CH3-
H4folate > 10-HCO-H4folate > H4folate (Gregory, 1996). All folate compounds are 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Chemical structure of vitamin B12. 
The R-position being occupied by one of the following substituents: CN- (cyanocobalamin),   
-OH (hydroxocobalamin), H2O- (aquacobalamin), -NO2 (nitritocobalamin), -SO3 
(sulphitocobalamin), -CH3 (methylcobalamin), or -5´-deoxyadenosyl (adenosylcobalamin).  
With kind permission from Kräutler et al., Vitamin B12 and B12-proteins, 1998.   16
endangered to oxidative degradation enhanced by light and heat, resulting in a 
splitting of the molecule into biologically inactive forms, of which p-
aminobenzoylglutamate is a major. If present in sufficient amounts, antioxidants, 
e.g. ascorbic acid and thiols, protect folate from being oxidised. The rate of 
reaction for folate degradation in the presence of oxygen depends on the type of 
folate derivative and the nature of the matrix, in which the folate compound occurs, 
in particular with respect to pH, buffer composition, catalytic trace elements and 
antioxidants (Eitenmiller & Landen, 1999a).  
 
FBP 
The high affinity folate-binding proteins (FBP) in mammalians exist as a 
membrane-bound folate receptor as well as a soluble form in milk and other body 
fluids (Anthony, 1996). FBP in bovine milk exist in concentrations about 8 mg/L 
(Salter et al., 1972), and binds approximately 1 mol of folate per mol protein at pH 
7.2 (Salter et al., 1981). The existence of a ‘milk folate binder’ was originally 
suggested by Ghitis and associates (1969). The complete amino acid sequence of 
this minor whey protein was determined by Svendsen et al. (1984). The molecule 
consists of a single polypeptide chain of 222 amino acid residues and eight 
disulphide bridges, and is reported to contain between 3-20% carbohydrate (Salter 
et al., 1981). A molecular weight of 25-40 kDa is suggested for FBP (Henderson, 
1990), similar to the molecular weight of β-lactoglobulin. Bovine milk FBP and 
FBP purified from human milk exhibit a high degree of amino acid sequence 
homology (Svendsen et al., 1982). Pasteurisation of milk (at 72 °C for 15 s) is 
suggested to result in heat-induced alterations of the FBP molecule (Gregory, 
1982). In contrast, FBP is shown to be relatively resistant to acidic environments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The structure of folate compounds.  
With kind permission from Strålsjö, Folates in Berries, 2003. 
N-CH-CH2-CH2-COOH
--N-CH-CH2-CH2-C-- N-C-CH2-CH2-COOH
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-CH3  (methyl) 5
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and are demonstrated to recover after e.g. gastric passage in 6-d-old goat kids 
(Salter & Mowlem, 1983). 
 
Methods of quantification 
Vitamin B12 
Vitamin B12 concentrations in foods are with a few exceptions only around 1 
µg/100g or lower, which makes analysis of the vitamin very demanding. Almost all 
data available for vitamin B12 in foods have been obtained by the reference method 
for assay of cobalamins, the microbiological assay (MA) using L. delbrueckii ssp 
lactis as test organism. For clinical samples (blood and plasma) rapid radio 
protein-binding assays (RPBA) are routinely used. A recent development of the 
protein-binding assay is the use of a biosensor technique to quantify cobalamins in 
foods. Although the various forms of vitamin B12 can be separated 
chromatographically, HPLC methods are in general not sensitive enough for 
determination of native cobalamins in biological materials, but are useful for 
quantification of vitamin tablets and fortified foods.  
 
Sample extraction 
Important aspects to consider when analysing vitamin B12 is to stabilise the native 
vitamin B12 derivatives and to choose methods that discriminate between 
biologically active and inactive analogues. All methods for cobalamin analyses of 
food samples require a preparative step prior to analysis. Since products with an 
animal origin are the sole food sources of vitamin B12 the vitamin must be 
extracted from protein-rich matrices under conditions that will not lead to 
destruction of the vitamin. The usual steps included in sample pretreatment are 
homogenisation of the sample in extraction buffer at slightly acidic pH, followed 
by autoclaving at approximately 120 °C for 10 min. After cooling of the sample 
either enzyme treatment, to release vitamin B12 from the food matrix followed by 
sample clean up, or sample clean-up procedures directly, e.g. filtering or 
centrifugation, are used. Usually, cyanide, metabisulphite or nitrite is added to 
samples before heat extraction in order to convert the native vitamin B12 
derivatives into one dominating form prior to quantification.  
 
The presence of one dominating vitamin analogue in the sample is necessary 
during quantification of total vitamin B12 by e.g. RPBA or MA for obtaining 
reliable results since a deviating response for various vitamin derivatives thereby 
can be avoided (Muhammad et al., 1993a, Muhammad et al., 1993b). Muhammad 
et al. (1993a) show results from an investigation on how five common vitamin B12 
derivatives in foods are converted into other derivatives by addition of an excess of 
cyanide, metabisulphite, or nitrite (Table 1). That study report cyanide to convert 
all but methylcobalamin into dicyanocobalamin, whereas addition of 
metabisulphite or nitrite only converts hydroxocobalamin into sulphitocobalamin 
or nitritocobalamin, respectively, leaving the remaining derivatives unaffected. In 
contrast, prior to characterisation of individual vitamin B12 derivatives by HPLC, 
the use of conversion substances during pre-treatment of samples is unnecessary. 
Extraction conditions have been shown to significantly affect the efficiency of the 
overall extraction process. It has therefore been suggested that the extraction   18
conditions should be optimised for each type of food sample in order to achieve 
reproducible and good recoveries for the complete analysis (Richardson et al., 
1978, Beck, 1979). 
 
Microbiological assay (MA) 
Over the years, growth response of various microorganisms has been used in 
quantification of cobalamins in foods and other biological materials. The 
microrganisms used have been Lactobacillus delbrueckii (former L. leichmannii), 
Escherichia coli,  Euglena gracilis, and  Ochromonas malhamensis. Here the 
AOAC official method (AOAC, 2000b) using the L. delbrueckii ssp lactis (ATCC 
7830) is discussed. The other microorganisms demonstrate different disadvantages, 
i.e., decreased sensitivity and/or lower specificity towards non-biological 
analogues.  
 
The AOAC Official Method 952.20 ‘Cobalamin (Vitamin B12 activity) in 
vitamin preparations’ uses the microbiological assay with cyanocobalamin as 
calibrant and addition of metabisulphite during sample pre-treatment. This MA 
method was originally developed for analysis of vitamin supplements, but has been 
extended to be valid also for food matrices. The test organism exhibits variable 
responses to various cobalamins. Similar growth responses are reported for cyano-, 
hydroxo-, sulphito-, nitrito-, and dicyanocobalamin (Muhammad et al., 1993b). 
However, a higher response is observed for adenosylcobalamin, whereas for 
methylcobalamin a lower growth response results. Using cyanocobalamin as 
calibrant and by addition of metabisulphite or nitrite in excess during sample 
preparation enables accurate determination only of hydroxo-, sulphito- and 
cyanocobalamin. However, the amount of adenosylcobalamin will be 
overestimated and the amount of methylcobalamin underestimated. If, instead, an 
excess of cyanide is added during the extraction procedure, accurate quantification 
is possible of all vitamin derivatives, except methylcobalamin that will be 
underestimated (Muhammad et al., 1993b). An important aspect when validating a 
method is the specificity. L. delbrueckii is reported to also utilise vitamin B12 
analogues that are lacking biological activity, e.g. deoxyribonucleotides, and 
deoxyribonucleosides in addition to biologically active cobalamins (Eitenmiller & 
Landen, 1999b). This might result in overestimation of actual cobalamin content.  
 
 
Table 1. Conversion of cobalamin derivatives after addition of cyanide, metabisulphite or 
nitrite 
 
 
 
 
 
 
diCN-Cbl, dicyanocobalamin; CH3-Cbl, methylcobalamin; SO3-Cbl, sulphitocobalamin; 
CN-Cbl, cyanocobalamin; Ado-Cbl, adenosylcobalamin; NO2-Cbl, nitritocobalamin. 
With kind permission from Muhammad et al., Food Chemistry, 1993.   
Conversion 
substances 
Hydroxo- 
Cbl 
Sulphito- 
Cbl 
Cyano- 
Cbl 
Adenosyl- 
Cbl 
Methyl- 
Cbl 
+ cyanide  diCN-Cbl diCN-Cbl diCN-Cbl  diCN-Cbl CH3-Cbl 
+ metabisulphite  SO3-Cbl SO3-Cbl CN-Cbl Ado-Cbl  CH3-Cbl 
+ nitrite  NO2-Cbl SO3-Cbl CN-Cbl Ado-Cbl  CH3-Cbl 
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Radio Protein-Binding Assay (RPBA) 
RPBA has been routinely used for vitamin B12 analysis in clinical samples since the 
1960s. The principle of this assay is based on the competition between added 
isotope-labelled cyanocobalamin (
57Co) versus cyanocobalamin from a sample, for 
a limited number of cobalamin-binding proteins. Hence, the concentration of 
cobalamin in the unknown sample is inversely proportional to the concentration of 
labelled cobalamin, and calculated from a calibration curve. Early types of RPBA 
for quantification of vitamin B12  in clinical specimens and foods were often 
inaccurate due to the binding-protein used responding not only to active vitamin 
B12 derivatives, but also to biologically inactive analogues. The specificity of such 
assays has been greatly improved by use of a vitamin B12-binding protein 
(generally hog intrinsic factor, IF) specific for the biologically active forms of the 
vitamin. Equivalent binding affinity of cyano-, dicyano, nitrito-, hydroxo- and 
methylcobalamins is reported (Muhammad et al., 1993a) for hog IF, whereas 
significantly deviating binding affinities were found for sulphito- and 
adenosylcobalamin. As for the MA, again, in order to achieve reliable results with 
the RPBA using cyanocobalamin as the calibrant, it is necessary to add cyanide 
during sample preparation to convert most native derivatives to dicyanocobalamin 
(see Table 1).   
 
Studies indicate that RPBA kits including IF as vitamin B12-binder, are suitable 
for food analysis (Richardson et al., 1978, Beck, 1979, Casey et al., 1982, Králová 
et al., 1982, Österdahl et al., 1986, Österdahl & Johansson, 1988, Andersson et al., 
1990). Using optimised extraction procedures, RPBA and MA procedures showed 
agreement for most foods; however, differences were noted often enough to 
conclude that the two methods are not universally interchangeable for the assay of 
all foods. In conclusion, previous work has shown that the RPBA could be reliable 
for food analysis provided that careful method validation including control of 
selectivity has been carried out. So far, most of the published work on method 
validation of RPBA used for food analyses is incomplete, especially concerning 
control of possible interference from food matrices. Not only the food matrix itself, 
but also conditions introduced during extraction procedures, e.g. buffer strength, 
pH, cyanide concentration, and added enzymes, might cause non-specific binding 
to kit material and thereby causing misleading results.  
 
Biomolecular Interaction Analysis (BIA) 
The optical biosensor protein-binding assay is the latest methodological 
development for vitamin B12 analysis in foods (Indyk et al., 2002). It is based on 
biospecific recognition of the analyte, cyanocobalamin, by a vitamin B12-binding 
protein. A special kit, QflexTM Kit Vitamin B12, is commercially available using 
an inhibition assay for the analysis, i.e., the analyte or an analogue is immobilized 
onto the surface of a sensor chip. A high molecular weight detecting molecule, 
such as a binding-protein of a defined concentration, is added to the sample. The 
binding-protein binds to the analyte, but at equilibrium some binding-proteins will 
remain free and are thereby capable of binding to the sensor surface. The detection 
principle relies on surface plasmon resonance (SPR), an electronic charge density 
wave phenomenon, which arises at the surface of a metal film when light is 
reflected onto the film under specific conditions.   20
 
Samples analysed by MA, by RPBA, and by the BIA method show good 
agreement (Indyk et al., 2002), but the BIA method demonstrates, so far, a lower 
sensitivity. This restricts, at the moment, its use to fortified foods, e.g. infant 
formulas and pharmaceutical vitamin mixtures.  
 
HPLC methods 
HPLC is the exclusive method enabling characterisation of different vitamin B12 
derivatives. It has been conveniently applied to quantification of vitamin B12 in 
supplements and pharmaceutical preparations (Li et al., 2000, Markopoulou et al., 
2002). For the milk matrix, a HPLC method based on UV detection with a 
detection limit of 0.2 µg vitamin B12/L milk is described (Gauch et al., 1992). 
Another study report native cobalamin pattern in milk, however, owing to low 
levels of the various vitamin B12 derivatives, quantification of eluted cobalamins 
was performed by RPBA (Fie et al., 1994a, Fie et al., 1994b). Viñas et al. (2003) 
present an evaluated HPLC method suitable for quantification of four vitamin B12 
derivatives in biological materials (beef liver, chicken blood, and human serum and 
urine). However, the sensitivity of the HPLC method makes it suitable only for 
pharmaceutical purposes. 
 
Folate 
Quantification of folate compounds is a challenge due to the instability of the 
vitamin and the low native amounts found in food products. Furthermore, the 
ability of folate derivatives to interconvert to other forms makes it even more 
difficult. Techniques potentially suitable for quantification of folate in foods 
include, as for vitamin B12, microbiological and competitive-binding assay 
procedures, HPLC methods, and even LC-MS methods (Gregory, 1989, Gregory, 
1996, Freisleben et al., 2003). The quantification of folate is complicated by the 
need to account for all derivatives, which could easily include several dozen 
compounds. In order to achieve reliable results, it should be emphasised, also here, 
that it is of critical importance to carefully optimise the sample preparation prior to 
quantification (reviewed by Martin, 1995). 
 
Sample extraction  
To prevent folate degradation, it is essential to protect samples by nitrogen, 
subdued light, and to cool the samples on ice throughout preparation. Pretreatment 
of food samples usually includes homogenisation in a buffer at close to neutral pH 
with added reducing agents, followed by heat extraction at 100 °C for about 10 
min. A deconjugation step using γ-glutamyl hydrolase (conjugase) to cleave the 
glutamate chain of the folate molecule producing mono-, di- or triglutamates is 
most often used prior to quantification. Different sources of γ-glutamyl hydrolase 
exist for folate deconjugation purposes. Chicken pancreas (CP) powder used in 
MA analysis (AOAC, 2000a) is a crude enzyme mix including lipase, α-amylase, 
and γ-glutamyl hydrolase, yielding a mix of mono- and diglutamates. In HPLC 
analysis, conjugases which produce monoglutamates, e.g., hog kidney (HK), 
human (HP) or rat plasma (RP), are used. Trienzyme treatment has been reported 
to increase the folate yield during analysis of complex food matrices (De Souza &   21
Eitenmiller, 1990, Martin et al., 1990, Tamura et al., 1997, Pfeiffer et al., 1997b, 
Lim et al., 1998, Aiso & Tamura, 1998, DeVries et al., 2001). Protease and α-
amylase treatment, followed by incubation with γ-glutamyl hydrolase, has been 
found to increase the folate yield by 85% in human milk compared with values 
after γ-glutamyl hydrolase treatment alone (Lim et al., 1998). Enzyme treatment is 
followed by heat denaturation of enzymes, dilution and sample purification using, 
e.g. centrifugation, filtering, solid-phase extraction, or affinity chromatography. 
 
Microbiological assay (MA) 
Microbiological growth assays serve as the traditional method of folate analysis in 
foods. The test microrganisms used in these assays have been Lactobacillus 
rhamnosus, Enterococcus hirae, and Pediococcus acidilatici (Eitenmiller & 
Landen, 1999a). Today the only officially recognised method for folate analysis is 
AOAC 992.05, MA using L. rhamnosus (ATCC 7469). It is applicable only to 
quantify the ‘free form of folic acid’ (AOAC 992.05, 2000), which restricts its 
application to fortified products only. A joint collaborative study with 13 
participants was recently carried out to quantify total folate by MA (L. rhamnosus, 
ATCC 7469) using trienzyme extraction for a wide range of cereal products. This 
method has now been recommended for Official First Action status with AOAC 
and First Approval status with AACC (American Association of Cereal Chemists) 
(DeVries et al., 2001). The response of L. rhamnosus (ATCC 7469) to native 
folate compounds decreases as the length of the glutamate chain increases (Goli & 
Vanderslice, 1992). Furthermore, it is discussed if the microorganism responds 
equally, on a molar basis, to various metabolically active forms (Newman & Tsai, 
1986, Goli & Vanderslice, 1989). Although the MA show this drawback, most data 
on folate levels compiled in food tables and used for labelling purposes are based 
on this method.   
 
Ligand-Binding Assays  
Various biospecific methods are used to quantify folate in clinical samples and in 
foods (Wigertz & Jägerstad, 1995, Indyk et al., 2000, Arcot et al., 2002, Strålsjö et 
al., 2003). Finglas & Morgan (1994) categorise these methods for determination of 
B-vitamins into two types, 1) methods based upon antibody recognition, radio-
immunoassays (RIA) and enzyme-linked immunosorbent assays (ELISA), and 2) 
assays based on competitive binding of vitamins to a vitamin-binding protein, radio 
protein-binding assays (RPBA) and enzyme protein-binding assays (EPBA).  
 
The radio protein-binding assay (RPBA) based on competitive binding of folate 
to a limited number of folate-binding proteins (FBP) is today routinely used for 
folate quantification in clinical samples. A study comparing several commercial 
RPBA kits for folate analysis of clinical samples observed problems with 
overestimation of folate concentrations due to improper standard calibration. 
Furthermore, they reported a possible small change in assay pH and matrix effects 
from clinical samples to contribute to a high variability found between kits and 
laboratories. In summary, they identified the need for further standardisation and 
optimisation of assay and extraction procedures (van den Berg et al., 1994). 
Attempts to subject the RPBA to folate analyses in foods have revealed setbacks 
such as low precision and variable response to different natural folate derivatives  22
(Givas & Gutcho, 1975, Shane et al., 1980, Gregory et al., 1982, De Souza & 
Eitenmiller, 1990, Finglas et al., 1993, Wigertz & Jägerstad, 1995). At prevailing 
assay pH of 9.2, a RPBA using FBP as vitamin-binder overestimates H4folate 
compared with folic acid and 5-CH3-H4folate, whereas the possible presence of 5-
HCO-H4folate is not detectable (Wigertz & Jägerstad, 1995). In addition, a recent 
study observes a striking difference (approximately 30%) in the binding affinity of 
the racemic mixture (6R,S)-5-CH3-H4folate compared to the natural 
diastereoisomer (6S)-5-CH3-H4folate (Strålsjö et al., 2003).  
 
Whereas the choice of calibrant and assay pH is known to be crucial for the 
RPBA (Givas & Gutcho, 1975, van den Berg et al., 1994), little attention has been 
given to disturbances caused by food matrix and buffers. Theobald et al., (1981) 
suggest that matrix effects might change the background radiation and unspecific 
binding in the assay, resulting in false results. Furthermore, sample preparation in 
connection with the application of RPBA for food analyses and the need of 
deconjugation are still being discussed (Shane et al., 1980, Finglas et al., 1993). 
Shane et al. (1980) report variable responses dependent on the glutamate chain 
length and considered the RPBA unreliable for the direct determination of 
polyglutamates, which again emphasises the importance of deconjugation 
procedures prior to RPBA quantification. Strålsjö et al. (2003) demonstrate an 
optimised RPBA method to be suitable for quantification of folate in a variety of 
berries containing mainly 5-CH3-H4folate.  
 
As already mentioned with regard to vitamin B12, a BIA method was recently 
developed for analysis of folate in milk and infant formula (Shane et al., 1980, 
Finglas et al., 1993, Indyk et al., 2000). An advantage is the avoidance of isotope 
handling. A disadvantage is expensive instruments. Moreover, another problem 
with this BIA method is the varying cross-reactivity of the antibody for folate 
derivatives besides folic acid and 5-CH3-H4folate, which restricts the method for 
quantification of fortified products, or products in which one folate form is 
dominating. 
 
HPLC and LC-MS methods 
Several HPLC techniques to separate folate derivatives in food and biological 
material have been established (Vahteristo et al., 1997, Pfeiffer et al., 1997b, 
Finglas et al., 1998, Konings et al., 2001, Stokes & Webb, 1999, Ndaw et al., 
2001, Horne, 2001, Jastrebova et al., 2003). However, HPLC data reported on 
contents of various folate derivatives in certain food products are sometimes 
contradictory, thereby stressing the importance of further method optimisation with 
respect to peak identification and quantification of native folate derivatives other 
than 5-CH3-H4folate (Finglas et al., 1998). Extraction, enzyme treatment, and 
subsequent clean-up of samples require optimisation to permit folate analysis in 
various types of food and to be suitable for subsequent HPLC quantification. Only 
a few studies have been published on folate in fermented milk and dairy products 
based on HPLC analyses (Müller, 1993, Wigertz et al., 1997, Vahteristo et al., 
1997, Konings et al., 2001, Lin & Young, 2000b, Lin & Young, 2000a, Young & 
Lin, 2000).  
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The most recent method for quantification of individual folate derivatives in 
foods and biological material is coupling HPLC with mass spectrometry (MS) 
(Doherty & Beecher, 2003, Pawlosky et al., 2003, Freisleben et al., 2003). LC-MS 
methods offer interesting possibilities. Compared with other analytical methods the 
use of LC-MS, and especially LC-MS-MS, enable, not only characterisation but 
also a superior specificity. The use of appropriate internal standards in the form of 
stable isotopes (e.g. [
13C5]folic acid), first reported by Pawlosky and Flanagan 
(2001), is an important advance in LC-MS methodology allowing correction for 
recovery losses and variation of ionisation yields caused by matrix interferences. 
LC-MS quantification of folate in foods is limited due to the existence of a variety 
of native folate derivatives, whereas only a low number of suitable commercial 
internal standards are available. The dominating content of 5-CH3-H4folate 
facilitates LC-MS quantification of folate in plasma (Freisleben et al., 2003). 
Freisleben et al. (2003) report the presence of 5-HCO-H4folate in wheat bread and 
spinach by LC-MS-MS quantification, not detectable by HPLC analysis due to 
weak fluorescence of this folate compound. An LC-MS method is therefore an 
especially interesting alternative for quantification of folate derivatives exhibiting 
poor fluorescence. Drawbacks for LC-MS methods used for food analysis are 
expensive equipment, absence of suitable commercially available internal 
standards, and so far, low sensitivities for some of the folate compounds. 
 
FBP 
Using an enzyme-linked immunosorbent assay (ELISA) originally developed by 
Høier-Madsen et al. (1986), the first data on FBP concentrations in processed and 
unprocessed bovine milk were presented by Wigertz et al. (1996). The ELISA 
principle is based on recognition of FBP by a polyclonal antibody raised against 
bovine milk FBP. The above-mentioned ELISA is of ‘sandwich type’, i.e., 
antibodies against the analyte are coupled to the well bottom of a microtiter plate. 
After addition of the analyte, a second portion of biotinylated antibodies is added, 
followed by a substrate addition yielding a colour shift measured 
spectrophotometrically. The concentration of FBP in an unknown sample is 
calculated from a calibration curve prepared from a standard of purified bovine 
milk FBP (Hoier-Madsen et al., 1986). No information is available about whether 
the response of the ELISA antibody deviates for FBP in complex with ligand and 
‘free’ FBP, respectively, or whether the antibody also recognises FBP that is 
structurally affected as a result of processing.  
 
A recently developed method for quantification of bovine milk FBP using a BIA 
technique is reported by Nygren et al. (2003). The principle of the BIA method is 
based on binding of FBP to folic acid linked to a surface, and the quantification 
necessitates thereby ‘free’ FBP. This enables quantification of the ‘free’ and 
‘bound’ FBP fractions, respectively, in a sample. First the ‘free’ fraction of FBP in 
a sample is quantified, and after adjustment of the pH below 5, followed by a cut-
off filtration to get rid of the endogenous bound folate, it is possible to quantify 
also the fraction of ‘bound FBP’. Comparison of the BIA method with the ELISA 
quantification of FBP demonstrates good agreement for samples in which FBP is 
found ‘free’, i.e., without a bound ligand. However, a striking difference between  24
the methods is seen in samples in which folate is bound to FBP, i.e., in which 
FBP:folate complexes are found.  
 
B vitamins and FBP in dairy products 
Content and occurrence  
Milk and dairy products are important sources of vitamin B12, especially for lacto 
vegetarians. The average amount of vitamin B12 in bovine milk is 0.4 µg/100g 
(range of 0.2-0.7 µg/100g) (reviewed by Renner, 1983). Only one glass of milk 
provides about 40% of the daily requirement of the vitamin (Livsmedelsverket, 
2002). The predominant amount of vitamin B12 in bovine milk is biosynthesised by 
microorganisms in the rumen (Scott, 1999). In milk, most of the vitamin B12 is 
protein bound. The reason of this is still unknown, although a protective effect 
against microbial breakdown has been suggested (Ford, 1974). Hydroxocobalamin, 
adenosylcobalamin and methylcobalamin are the major vitamin B12 derivatives 
found in bovine milk and in hard cheese (Farquharson & Adams, 1976, Fie et al., 
1994b). Scott & Bishop (1986, 1988) report vitamin B12 concentrations in a variety 
of fermented dairy products on the UK market. They find a reduced content of 
vitamin B12 in fermented milk (0.1-0.2 µg/100g) compared to pasteurised milk. 
Hard and blue cheeses of different types are shown to contain between 1.0 and 2.1 
µg vitamin B12/100g, whereas cottage cheese contains 0.7 µg/100g. 
 
Although the folate concentration in milk is only about 5 µg/100g, an increase of 
the folate content usually results from fermentation of milk and whey products (Lin 
& Young, 2000b, Lin & Young, 2000a, Crittenden et al., 2003). Furthermore, milk 
is of interest due to its content of FBP. Like vitamin B12, folate in bovine milk is 
biosynthesised by microorganisms in the rumen of the cow. The dominating folate 
derivative in milk is 5-CH3-H4folate (Gregory et al., 1984, Vahteristo et al., 1997). 
Lin & Young (2000a) and Wigertz et al. (1996b) demonstrate 5-CH3-H4folate to be 
the major folate derivative also in fermented milk, other forms also reported to 
exist in fermented milks are H4folate and 5-HCO-H4folate (Müller, 1993, Lin & 
Young,  2000b, Konings et al., 2001). However, it must be stressed that 
quantification of 5-HCO-H4folate by HPLC is very difficult due to a low 
fluorescence of this form compared with other reduced folate derivatives. Food 
composition tables, based on folate quantification by microbiological assays, report 
total folate content of between 12 and 18 µg folate/100g for various fermented 
milks (Holland et al., 1991, Souci et al., 1994, Swedish National Food 
Administration, 1996). Cottage cheese contains between 12 µg and 27 µg 
folate/100g based on quantification by microbiological assays (Renner, 1989) and 
HPLC (Wigertz et al., 1997). Ripened soft cheese, e.g. Brie, Camembert and blue 
cheese, has been demonstrated to contain between 50 µg and 100 µg folate/100g, 
probably due to the synthesis of folate by microorganisms during ripening (Renner, 
1989). A variety of hard cheeses, e.g. Edam, Gouda and Cheddar, have been 
reported to contain 20-40 µg of total folate/100g (Scott & Bishop, 1988, Holland 
et al., 1991, Swedish National Food Administration, 1996). HPLC analyses show 
lower folate concentrations in hard cheeses; values of 7-12 µg folate/100g, with 5-
HCO-H4folate as the dominating derivative (Müller, 1993, Konings et al., 2001), 
and 12-18 µg/100g of 5-CH3-H4folate (Wigertz et al., 1997) are reported.   25
However, as also valid for folate analysis in fermented milks by HPLC, the 
analytical methodology requires further improvement regarding complex matrices 
such as cheese. 
 
Almost all naturally occurring folate in milk is bound to FBP (Ghitis et al., 
1969). FBP concentrations in pasteurised bovine milk are found in the range of 
160-210 nmol/L, highly equivalent to the folate concentration of 110-220 nmol/L 
(review by Forssén et al., 2000). The majority of FBP in bovine milk exist as the 
soluble form, although a small amount of particulate FBP are found. The soluble 
form of FBP has been suggested to play a role in folate transport in e.g. serum and 
milk, whereas the particulate form is anchored in the cell membrane and associated 
with membrane transport of folate (reviewed by Wagner, 1985 and Anthony, 
1996). FBP is destroyed by heat treatment of milk beyond pasteurisation at 72 °C. 
Hence, no or very low amounts of FBP are found in fermented milks, such as 
yoghurt. Wigertz et al. (1996) demonstrate FBP concentrations of < 10 nmol/L in 
UHT milk and yoghurt. 
 
Effects from food processing and storage  
Pasteurisation and ultra-high-temperature (UHT) treatment of bovine milk results, 
also for vitamin B12, in minor losses of only < 10% as summarised by Biesalski and 
Back (2002). The vitamin B12 content is unaltered after pasteurisation of milk and 
during storage of UHT milk at 7 °C for up to 18 weeks, whereas vitamin B12 
concentration is shown to decrease after 10 weeks storage at 23°C (Andersson & 
Öste, 1992a, Andersson & Öste, 1992b).  
 
Fermentation of milk to yoghurt is shown to reduce the content of vitamin B12 
(Reddy et al., 1975, Alm, 1982, Friend et al., 1983, Rao et al., 1984, Scott & 
Bishop, 1986). However, early studies (Janicki & Obrusiewicz, 1970, Cerna & 
Hrabova, 1977) report particular strains of Leuconostoc and Propionibacterium to 
increase the vitamin B12 content substantially during fermentation of milk, and 
during production of Kefir and hard cheese. During cheese making 10-50% of the 
vitamin B12 content from the starting milk is recovered in cheese (Scott & Bishop, 
1988, Biesalski & Back, 2002). It must be emphasised, though, that these results 
are based on quantification of vitamin B12 in retail cheeses. To our knowledge, no 
direct quantification of vitamin B12 in whey fractions has been performed. 
However, a large portion of the vitamin is assumed to be lost with the whey (Scott 
& Bishop, 1988, Biesalski & Back, 2002).  
 
The chemical reactivity of some important folate compounds makes the vitamin 
one of the most vulnerable to losses during food processing. Oxidative degradation 
enhanced by light and heat is responsible for a major part of these losses.     
Pasteurisation, however, has only minor effects on the folate content of milk, 
causing losses of less than 10% (Renner, 1989, Andersson & Öste, 1992a, 
Andersson & Öste, 1992b, Wigertz et al., 1996). According to a study by 
Andersson (1993), folate levels in pasteurised milk were not reduced during 
storage beyond the expiry date. Losses of folate, however, are observed during 
UHT treatment of milk (Renner, 1989, Wigertz et al., 1996) and the storage of 
aseptically packed UHT milk (Renner, 1989, Wigertz et al., 1996, Andersson & 
Öste, 1992a, Andersson & Öste, 1992b). Andersson & Öste (1992) reported a 57%  26
retention of folate during indirect UHT treatment, with an oxygen level of 5.4 ppm 
in the milk. When the oxygen level was reduced to 0.6 ppm, 96% of the folate was 
retained. Milk in packages with an oxygen-permeable seal lost all folate within 3 
weeks of storage at room temperature. A storage study performed on UHT milk 
containing 0.3 ppm dissolved oxygen stored at 5 °C for 4 months showed no loss 
of 5-CH3-H4folate (Wigertz et al., 1996). 
 
Several investigators have examined various strains of lactic acid bacteria for 
their ability to synthesise or utilise folate during fermentation of milk (Reddy et al., 
1975, Cerna & Hrabova, 1977, Alm, 1982, Friend et al., 1983, Rao et al., 1984). 
Crittenden et al. (2003) find that S. thermophilus, bifidobacteria, and E. faecium 
elevate the folate content after fermentation of skim milk, whereas fermentation 
with lactobacilli generally deplete the folate content. Results from a study by Lin 
and Young (2000a) demonstrate 2-3-fold increase of the folate content in milk after 
fermentation by two B. longum strains. In another recent study they report that 
addition of 2% lactose to milk increase folate synthesis during fermentation by the 
two strains involved in yoghurt starter cultures, S. thermophilus and L. bulgaricus 
(Lin & Young, 2000a). They also show that the length of the incubation period (up 
to 18 h) significantly affects the folate content. In the presence of added lactose, 
the longer incubation period result in higher folate content, whereas fermentation 
for 18 h in the absence of added lactose result in a substantial decrease in folate 
content compared with the initial milk. The latter results were in line with earlier 
findings from the same investigators (Lin & Young, 2000b). In accordance with 
results obtained previously (Reddy et al., 1975), Lin & Young (2000b) show that 
the folate concentrations in fermented milk decrease by up to 28% during storage 
at 4 ºC for two weeks.  
 
Few studies have investigated whether storage and ripening affect the folate 
content of hard cheese. Reif et al. (1975) observe that the starter culture of a 
cottage cheese actively synthesise folate during the setting period, resulting in a 
significant increase in folate concentrations in the final product. Wigertz et al. 
(1996) report no significant change in the concentration of 5-CH3-H4folate in hard 
cheese over a two-week period after manufacture, whereas a significant decrease 
(about 30 %) was seen in cheese after storage for six months. Again, one must bear 
in mind that biosynthesis or utilisations of B vitamins by lactic acid-producing 
bacteria depend greatly on the strain and the manufacturing procedure used. Hence, 
stages of cheese-making, e.g., the lowering of pH, the coagulation of milk proteins 
followed by drainage of whey, and the ripening procedure through the action of 
different enzymes or microorganisms, could result in either increased and 
decreased levels of folate in cheese.  
 
  Pasteurisation of milk (at 74 °C for 4 s) results in a significant reduction of the 
concentration of FBP from 211 ± 7 nmol/L to 168 ± 20 nmol/L (Wigertz et al., 
1996). These findings are in good agreement with earlier findings by Ford (1974) 
who demonstrate a 10% reduction in folate-binding of milk after low-temperature-
long-term pasteurisation. In a study by Gregory (1982), heat-induced alteration of 
the FBP molecule was observed from pasteurisation, suggesting a change in folate-
binding characteristics. In contrast to this, Kohashi et al. (1985), who compared the 
folate-binding capacity of raw milk with pasteurised milks (at 63 °C for 30 min, at   27
75 °C for 15 s, and at 120 °C for 1 s), observed an almost complete reduction of 
the folate-binding capacity. Conflicting results from these studies could be caused 
by the fact that common pasteurisation temperatures are very close to those at 
which denaturation of FBP takes place. Thus, small fluctuations in processing 
conditions may have a relatively large impact on the extent of FBP denaturation. 
The heat treatment process at 140 °C for a few seconds explains the low levels of 
FBP found in UHT milk reported by Wigertz et al. (1996). During production of 
yoghurt the milk is subjected to heat treatment (approximately at 95 °C for 5 min) 
prior to inoculation, also resulting in denaturation of FBP (Wigertz et al., 1996). 
In spite of the high temperatures employed in the spray-drying process, most of the 
FBP is retained in milk powder (Svendsen et al., 1979, Wigertz et al., 1997). 
During cheese-making Wigertz et al. (1997) observe half the original amount of 
FBP from milk recovered in the whey fraction, 97 nmol FBP/L whey compared 
with 160-210 nmol FBP/L milk. FBP analysis of cottage cheese and hard cheese 
demonstrate 540 nmol and 13 nmol FBP/kg cheese, respectively.  
 
Folate bioavailability 
Absorption and physiology 
Prior to absorption, deconjugation of folate polyglutamates from foods to 
monoglutamates by a γ-glutamyl hydrolase (conjugase) is required (Halsted, 1990). 
Reisenauer et al. (1977) report the existence of two separate γ-glutamyl hydrolase 
activities in human jejunal mucosa: one soluble and intracellular; the other 
membrane-bound and concentrated in the brush border. Human brush border γ-
glutamyl hydrolase is a zinc-dependent exo-peptidase with optimum activity at pH 
6.5, resulting in stepwise hydrolysis of polyglutamate folate. This enzyme has been 
shown to play the principal role in the digestion of dietary folate.  
 
The monoglutamate folate compounds are absorbed by an active energy-
dependent, carrier-mediated process at physiological concentrations and by passive 
absorption at higher concentrations (Selhub et al., 1984). Absorption takes place 
mainly in the jejunum and is markedly influenced by pH with a maximum 
absorption at pH 6.3. During transport of physiological concentrations of folate 
over the intestinal mucosa absorbed folate derivatives are converted to 5-CH3-
H4folate and thereafter transported to the liver, which is the storage organ of folate 
as polyglutamates. A portion of absorbed folate is on the first pass retained in the 
liver, called ‘first pass effect’ (Steinberg et al., 1979). The liver is reported to 
secrete folate into the bile. The significance of this process and the efficiency of 
reabsorption have not yet been determined in humans, as summarised by Gregory 
(1995). From the liver, monoglutamate 5-CH3-H4folate is transported in the 
systemic circulation to other tissues were it is metabolised into H4folate and used 
as one-carbon donor, or again converted to polyglutamates for storage (reviewed 
by Finglas et al., 2003).  
 
Bioavailability is commonly defined as the absorption and metabolic utilisation 
of a nutrient, involving processes of intestinal absorption, transport, metabolism 
and excretion (Gregory, 1995). Folate bioavailability can be influenced by several 
intrinsic or extrinsic factors. Directly linked to the organism are folate status, 
health and gastrointestinal function, and antagonistic effects from use of drugs and  28
alcohol. Extrinsic factors are many depending on the ingested folate (e.g. oxidation 
status and substituent, length of polyglutamate chain), the food matrix (e.g. folate 
interaction with fibres, and substances with antifolate activity), or processing and 
storage (Jackson, 1997, Gregory, 2001). 
 
Models for assessment 
Many different experimental models have been applied with the goal of assessing 
folate bioavailability. Initially, often bioassays were performed to determine folate 
bioavailability using rats (Abad & Gregory, 1987, Keagy & Oace, 1989, Swiatlo et 
al., 1990), pigs (Natsuhori et al., 1991), or chicken (Ristow et al., 1982). Bioassays 
enable determination of folate concentrations in several response tissues, such as 
liver, kidneys, serum and whole blood, and allow assessing growth or reproduction 
activity as parameters for folate bioavailability. Concerns about the 
appropriateness of bioassays in order to predict folate metabolism in humans have 
been raised, due to quantitative and qualitative physiological differences between 
species, and interactions such as coprophagy in rat bioassays (Gregory, 2001). 
 
In vitro methods allow more rapid and easily performed screening of test 
material compared to in vivo studies. Furthermore, tests enable strictly controlled 
conditions thereby avoiding e.g. pathological interferences. In a recent study the 
bioaccessibility of folic acid and (6S)-5-CH3-H4folate from folate-fortified 
pasteurised or UHT-treated milk, both in the presence and in the absence of FBP, 
using a dynamic in vitro gastrointestinal model (TIM) was investigated (Verwei et 
al., 2003). Results demonstrate milk to be a suitable carrier for supplemental folate, 
since 60-70% of the folate is released from the milk matrix and is found available 
for absorption in the small intestinal lumen. Using this in vitro model, a significant 
decrease of the bioaccessibility of folic acid is seen after addition of FBP in 
equimolar amounts to folate, whereas the addition of FBP does not affect the 
bioaccessibility of 5-CH3-H4folate. However, in vitro methods can reflect the 
complexity of in vivo folate absorption, deconjugation and metabolism only to a 
limited extent, and validation with corresponding human in vivo situation is crucial. 
For instance, in the above-mentioned in vitro model, the cellular transport of folate 
over the intestinal mucosa is replaced by passive diffusion over a membrane with a 
cut-off of 5 kDa. 
 
Studies involving human subjects provide the best means to assess folate 
bioavailability, by use of e.g. long-term or short-term protocols. Long-term folate 
kinetics are usually investigating the impact of repeated folate supplementation on 
folate status, e.g. by feeding fortified or natural foods and compare those to folic 
acid supplements (Sauberlich et al., 1987, Cuskelly et al., 1999, Cuskelly et al., 
1996, Johansson et al., 2002). Subsequently, folate concentrations in whole blood, 
erythrocytes, or fastened plasma are quantified, which reflect the folate status of 
the past three months. These studies are intensive in respect to costs and time. 
Short-term folate absorption and elimination kinetics are often studied after 
application of a single oral folate dose, in form of a pharmaceutical preparation, or 
a food either folate-fortified or naturally containing folate. Comparison of the area 
under the plasma response curve (AUC) or urinary folate excretion allows 
determination of relative bioavailability of different folate derivatives, from   29
various doses or application techniques (Tamura & Stokstad, 1973, Pfeiffer et al., 
1997a, Prinz-Langenohl et al., 1999). A drawback of some short-term protocols for 
the determination of folate kinetics is the fact that the application of a single folate 
dose of physiological magnitude only results in a small plasma and urine folate 
response. Therefore, often pharmacological doses (Loew et al., 1987) or 
preloading of body stores are used (Tamura & Stokstad, 1973), which do not 
reflect physiological conditions.  
 
A model for assessment of folate bioavailability recently introduced involves 
human ileostomists. A major advantage with ileostomists in folate research is that 
interference from folate synthesis by microbes in the large intestine can be avoided. 
A folate absorption study using nine healthy ileostomists consuming daily either 
one litre of milk, one litre of fermented milk, or one litre of a carbonised soft drink, 
together with a standardised diet, was performed (Wigertz, 1997). That study 
shows that the subjects excrete less folate in their ileostomal effluents after 
consumption of either of the milk products compared with after consumption of the 
carbonised soft drink. Authors interpret results as an improved absorption 
efficiency of dietary folate after incorporation of milk or fermented milk into a 
mixed diet occurred. This study was the first using human ileostomists as a model 
to assess folate absorption, and it needs to be repeated for dairy products under 
more controlled conditions. A recent ileostomy study show folate bioavailability 
from spinach to be 80% calculated from AUC and compared to an oral dose of 
folic acid as reference dose (Konings et al., 2002). Another newly performed 
ileostomist study (Witthöft et al., 2003), report folate from strawberries and 
broccoli to be approximately 65 and 50% bioavailable, respectively, as calculated 
from AUC. In contrast to the spinach study, in the latter study the reference dose to 
which the test food AUCs where compared, was an intra-muscular injection of 
(6S)-5-CH3-H4folate.  
 
A few years ago, Gregory and his co-workers (von den Porten et al., 1992, Stites 
et al., 1997, Pfeiffer et al., 1997a, Boddie et al., 2000) introduced the use of stable 
isotope protocols. The incorporation of isotope labelled folate compounds (from 
fortified food samples) into the diet provides a tool to estimate folate turnover by 
urinary and faecal excretion of the labelled compounds and their metabolites 
(Pfeiffer et al., 1997a). An advantage with stable isotopes is that labelled folate 
compounds from the dose, and endogenous folate compounds from body stores can 
be distinguished.  
 
A food constituent of particular interest for folate bioavailability is the folate-
binding proteins (FBP) in milk. The physiological role of FBP is unclear. Ford 
(1974) suggests that FBP in human milk may initially act in the mammary gland as 
a trapping agent to accumulate folate from blood plasma into the milk. It has been 
speculated that FBP protects folate from microbial uptake and degradation (Tani & 
Iwai, 1984, Jones & Nixon, 2002) and could enhance folate absorption by mucosal 
cells (Colman et al., 1981, Salter & Blakeborough,  1988). However, this 
enhancement was not found in rat studies (Tani et al., 1983, Said et al., 1986), 
which rather showed that FBP reduce the rate of folate absorption.  
 
In one of these rat studies (Tani et al., 1983), it was also found that under acidic 
conditions in the stomach folic acid is released from FBP, but recombines after  30
reaching the intestine. This is in line with the observation that the dissociation of 
folate occurs at pH of approximately 5 and lower (Ghitis et al., 1969). However, to 
which extent FBP resists the gastrointestinal passage has been very little studied. 
Salter & Mowlem (1983) demonstrated ‘survival’ of FBP activity in six-day-old 
goat kids. The situation might though be different in adults with a more matured 
digestion system, but no such studies are available. 
 
Protein-bound and free folate, respectively, are absorbed in different ways in the 
small intestine. Whereas free folate monoglutamates are absorbed in the jejunum, 
is protein-bound folate mainly absorbed in the ileum at a much slower rate (Said et 
al., 1986). A slower rate of absorption, coupled with protection from intestinal 
bacteria is suggested to improve the bioavailability of folate when bound to 
proteins in milk (Ford, 1974). In fact, breast-fed babies have been reported to have 
a better folate status than bottle-fed babies. Whereas breast-fed babies sustain their 
folate status on an intake of 55 µg folate/d, require bottle-fed babies 78 µg/d. It has 
been speculated that the discrepancy is due to the occurrence of FBP in human 
milk that is not present in heat-processed milk formulas (Ek & Magnus, 1979, Ek 
& Magnus, 1980). However, the ileostomy study by Wigertz et al. (Wigertz, 1997), 
mentioned above, comparing excreted amounts of dietary 5-CH3-H4folate, shows 
an equal excretion of folate after consumption of milk and fermented milk, 
respectively, despite that the fermented milk did not contain any FBP.  
 
The bioavailability of naturally occurring folate compounds in most foods has 
not been fully determined under conditions of actual consumption, neither 
including the consequences of interactions between foods in a mixed diet. In 
conclusion, data on folate bioavailability from dairy products needs to be further 
elucidated using evaluated experimental models. Information about the 
bioavailability of various natural folate derivatives compared with folic acid, and 
the effect of food matrix on folate bioavailability is required. Furthermore, studies 
investigating the possible nutritional role of bovine FBP are warranted.  
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Objectives and experimental designs 
 
Average folate intake is still below recommendations in several population groups 
and authorities throughout Europe are at the moment struggling to develop 
strategies to improve folate intake to beneficial levels. The issue whether or not to 
fortify food products with folic acid is widely discussed. Still today, little reliable 
information is available on actual concentrations of folate and vitamin B12 in foods, 
or on the impact of food processing techniques on vitamin retention. A nutritional 
role of the bovine milk folate-binding proteins (FBP) on folate absorption has long 
been speculated upon. Many of the investigations in this field were, however, 
performed with old and indirect quantification methods, enabling no firm 
conclusions to be made. Furthermore, knowledge about folate bioavailability from 
different food sources, both products with native folate content and folate-fortified 
products, is still incomplete.  
 
Specific objectives of the present work were: 
 
·  To optimise preparation of dairy samples prior to analysis, and to modify 
and evaluate a radio protein-binding assay (RPBA) method for the 
quantification of vitamin B12 and folate in dairy products.  
Aspects studied were composition of extraction buffers, choice of calibrants, 
absence of matrix effects, linearity, recoveries, and accuracy (Papers I-II). 
 
·  To map the retention of vitamin B12 and folate during the manufacturing 
process of six fermented dairy products.  
The evaluated RPBA was used to study vitamin retention during one single 
manufacture batch of six fermented dairy products. Retention studies mainly 
focused on vitamin B12 for which samples throughout the manufacturing procedure 
were analysed (Paper I). Milk and “ready to consume” products from studied 
products were also analysed for folate, and folate retention was discussed.  
 
· To study folate bioavailability from folate-fortified milk products, with 
focus on the nutritional role of bovine milk FBP during gastrointestinal 
passage.  
Folate bioavailability was studied both in vitro and in vivo. In the in vitro studies 
the effects on folate bioaccessibility of; 1) dairy matrix, 2) folate form used for 
fortification, and 3) the effect of FBP, were investigated (Paper III). In addition, 
the stability and binding characteristics of FBP for 5-CH3-H4folate and folic acid 
during gastric passage were investigated (Paper IV). The human study (Paper V) 
focused on the bioavailability of the natural folate form, (6S)-5-CH3-H4folate, from 
folate-fortified milk and fermented milk, and the effect and stability of FBP were 
also studied. Priority was given to folate for bioavailability studies due to the 
massive interest in folate concerning health benefits, dietary recommendations and 
the issue raised about folate fortification of food. The human ileostomy model, the 
TIM model and the expertise around these models were also available exclusively 
for the folate application.  
 
For an overview of the experimental designs see Table 2.  32  33
Material and methods 
 
The following chapter gives a brief description of materials and methods used. For 
an overview see Table 2. More detailed information is found in Papers I-V. 
 
Material 
Standards 
Cyanocobalamin used as calibrant in the RPBA, was obtained from Sigma-Aldrich 
(St Louis, MO, USA). (Paper I) 
(6R,S)-tetrahydrofolic acid (H4folate, trihydrochloride salt), (6R,S)-5-methyl-
tetrahydrofolic acid (5-CH3-H4folate, calcium salt), (6R,S)-5-formyltetrahydrofolic 
acid (5-HCO-H4folate, calcium salt), pteroyl-L-glutamic acid (PteGlu), pteroyl-di-
γ-L-glutamic acid (PteGlu2), pteroyl-tri-γ-L-glutamic acid (PteGlu3), pterin-6-
carboxylic acid (Pt-6-COOH) and para-aminobenzoyl-L-glutamic acid (pABG), all 
used as calibrants in the RPBA, were obtained from Schircks Laboratories (Jona, 
Switzerland). (Paper II) 
Folic acid and (6S)-5-methyltetrahydrofolic acid (5-CH3-H4folate, sodium salt), 
used for fortification of dairy products for in vitro studies on folate 
bioaccessibility, were obtained from Eprova AG (Schauffhausen, Switzerland). 
(Paper III) 
Radio labelled folate compounds, [
3H]-folic acid and [
14C]-(6R,S)-5-CH3-H4folate 
used in studies of FBP´s binding characteristics under gastric passage were 
obtained from Amersham Pharmacia (Buckinghamshire, England). Unlabelled 
folic acid and (6R,S)-5-CH3-H4folate (calcium salt) were obtained from Schircks 
Laboratories (Jona, Switzerland). (Paper IV) 
(6S)-Ca-5-methyltetrahydrofolate (5-CH3-H4folate, calcium salt), used for in vivo 
studies on folate bioavailability was obtained from Eprova AG (Schauffhausen, 
Switzerland). The concentration was corrected for water and calcium contents. 
(Paper V)  
Purity of standards were determined using the molar extinction coefficients 
described elsewhere (van den Berg et al., 1994, Eitenmiller & Landen, 1999b, 
Eitenmiller & Landen, 1999a).  
The FBP calibrant used in ELISA analysis was obtained from the Central Hospital 
Hillerød (Hillerød, Denmark). (Papers III-V) 
 
Dairy products 
Reference dairy materials 
A concentrated whey protein powder, wpc 65, (supplied by Arla Foods, Götene, 
Sweden) was used as an in-house reference material for vitamin B12 and folate 
analyses using the RPBA method, and for ELISA quantification of FBP. Wpc 65 
was included parallel to dairy samples in every extraction and quantified in 
subsequent RPBA or ELISA. CRM 421 (vitamin enriched milk powder), a 
certified reference material obtained from the European Commission (Joint 
Research Centre IRMM, Geel, Belgium) was used to control method accuracy and 
to enable comparison of different analytical methods. CRM 421 was extracted and  34
quantified as a dairy sample in vitamin B12 and folate analysis using the RPBA 
method. These reference materials were subsampled and stored frozen at -18°C 
and -80°C, respectively, until analysis.  
 
Dairy samples for process retention studies 
Six dairy products were selected for the evaluation and optimisation of sample pre-
treatment and quantification of vitamin B12 and folate by RPBA, and for studies of 
the retention of these vitamins during the manufacturing process. Samples were 
collected from one single manufacture batch, and during the subsequent storage 
period, from the dairy plants of Arla Foods in Linköping (fermented milks, 
Filmjölk and Yoghurt naturell), Skövde (cottage cheese, Keso
®), Kalmar (hard 
cheeses, Herrgård
® and Grevé
®) and Kvibille (blue cheese, Kvibille ädel). Samples 
were taken according to the scheme outlined in Fig. 4. Approximately 1 kg product 
was collected at each point, and these portions were divided into ten subsamples 
and were stored at -20ºC until analysis. Milk before and after heat treatment at 76 
°C for 16 s and 96 °C for 5 min, respectively, was collected at the dairy plant of 
Arla Foods in Stockholm. All milk samples prior to and after heat treatment 
originated from the same milk silo. (Paper I)  
 
Fortified dairy products for studies of folate bioavailability and the effect of FBP  
Dutch pasteurised milk and Swedish commercially available yoghurt were used to 
prepare eight different test products for studies of folate bioaccessibility including 
the effect of FBP using a dynamic in vitro gastrointestinal model (TIM). 
Fortification of yoghurt with folic acid or the natural folate diastereoisomer (6S)-5-
CH3-H4folate and FBP, and fortification of pasteurised milk with the natural folate 
diastereoisomer (6S)-5-CH3-H4folate and FBP, were performed 1 h prior to the 
experiment by stirring the fortificants into the test portion. Folic acid-fortified 
pasteurised milk was commercially prepared and obtained from Campina (The 
Netherlands). A portion of 300 g test food applied into the TIM model provided 
260-350 nmol folate and equimolar amounts of FBP. For details see Table 2 and 
Paper III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Sampling scheme for studies on vitamin retention during manufacture of six 
fermented dairy products. 
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A whey protein concentrate (wpc 75, whey powder containing 75% protein and 
15% lipids) obtained from Arla Foods Innovation (Stockholm, Sweden) was used 
for studies on the fate and binding characteristics of FBP for folic acid and 5-CH3-
H4folate during gastric and duodenal passage of the TIM model. The whey powder 
had an endogenous folate content of ca 9000 nmol/kg and an endogenous FBP 
content of ca 20 000 nmol/kg. Whey solutions were prepared in phosphate buffer, 
pH 7, with a FBP concentration of ca 160 nmol/L and fortified with a mix of radio 
labelled and unlabelled folate, either [
3H]-folic acid and folic acid, or [
14C]-(6R,S)-
5-CH3-H4folate and (6R,S)-5-CH3-H4folate, to a final fortification concentration of 
approximately 160 nmol/L. (Paper IV) 
 
The products used for studies of folate bioavailability in vivo were pasteurised 
milk fortified with the natural folate diastereomer (6S)-5-CH3-H4folate + FBP 
(aiming at equimolar amounts) and two fermented milks; one fortified with (6S)-5-
CH3-H4folate and one fortified with (6S)-5-CH3-H4folate + FBP (aiming at 
equimolar amounts). FBP was added via the above described whey powder, wpc 
75. The pasteurised milk product was produced in a single batch in a pilot plant of 
Arla Foods Innovation (Stockholm, Sweden). The milk was bottled and stored at -
20ºC until use. For the fermented milk products a commercially available product 
on the Swedish market was fortified with folate and FBP 30 min prior to the start 
of the experiment by stirring the fortificants into the test portion of the fermented 
milk. A portion of 400 g of the test food was given to the human volunteers 
providing 241-542 nmol folate and 156-442 nmol FBP. For details see Table 2 and 
Paper V. 
 
Methods 
Models for evaluation of folate bioavailability 
The dynamic in vitro gastrointestinal model (TIM) 
TNO´s (TNO Nutrition and Food Research, the Netherlands) dynamic in vitro 
gastroIntestinal Model (TIM) was used to study the amount of folate, from folate- 
and FBP-fortified yoghurt and milk, available for absorption in the small intestine. 
The stability and binding characteristics of FBP for 5-CH3-H4folate and folic acid 
after passage through the stomach and the small intestine were also investigated in 
TIM. (Papers III & IV) 
 
The TIM system (Fig. 5) has been described by Minekus et al. (1995). For 
details about the folate application see Verwei et al. (2003). The models used in 
these studies simulated the gastrointestinal conditions of a healthy adult human. 
The gastric small-intestinal model comprises four connected compartments that 
represent the stomach, duodenum, jejunum and ileum, respectively. Each 
compartment consists of a glass outer wall with a flexible inner wall. The pH is 
continuously measured in the four compartments and regulated by addition of 
hydrochloric acid or sodium bicarbonate. The pH values, as well as the gastric 
emptying and small-intestinal passage of the food, are computer-controlled events 
according to pre-set curves based on literature information for human in vivo 
conditions. Artificial oral fluid and gastric juice with lipase and pepsin are 
gradually added into the gastric compartment. Bile, pancreatic juice and  36
electrolytes are gradually added into the duodenal compartment. The flexible wall 
is surrounded by water heated to 37 ºC. Mixing of the food with the ‘secreted’ 
enzymes is ensured by peristaltic movements in the gastrointestinal tract. The 
jejunal and ileal compartments are connected with semi-permeable hollow fibre 
membranes with a cut-off of 5 kDa, which mimic the passive absorption of 
digested products and water (Fig. 5, points N, O and P). During passage of the test 
food through TIM, total jejunal and ileal dialysate were collected during 0-1, 1-2, 
2-3 and 3-5 h. The dialysate fractions contained the absorbable (bioaccessible) 
fraction. The non-absorbed folate fractions were collected after passage through 
the ileo-coecal valve as ‘ileal delivery’ (Fig. 5, point H). The ileal delivery was 
collected as one pooled sample during 0-5 h.  
 
The human ileostomy model 
A human ileostomy model (Fig. 6) described in detail by Witthöft et al. (2003) was 
used to study relative folate bioavailability and in vivo effects of FBP on folate 
retention after gastrointestinal passage of dairy products (Paper V). The model 
determines short-term folate absorption from single test food doses compared with 
pharmaceutical folate doses. Collection of the ileostomal effluent in individual 
fractions every second hour over ten hours post-dose reflected not only non-
absorbed folate, but showed also a time pattern of the gastrointestinal passage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Schematic diagram of the dynamic in vitro gastrointestinal model (TIM). 
A. gastric compartment; B. pyloric sphincter; C. duodenal compartment; D. peristaltic 
valve; E. jejunal compartment; F. peristaltic valve; G. ileal compartment; H. ileo-caecal 
valve; I. pH electrodes; J. gastric secretion bottles with acid and enzymes; K. duodenal 
secretion bottles with bile, pancreatin, bicarbonate; L. secretion of bicarbonate to control 
the intestinal pH; M. pre-filter system; N. hollow fibre semi-permeable membrane system; 
O. water absorption system; P. closed dialysing system.  
With kind permission from Verwei et al., Journal of Nutrition, 2003. 
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Urinary excretion of folate, or the absence of increased urinary excretion, was 
evaluated to ensure that the ingested doses were in the physiological range.  
 
Nine healthy subjects with pre-saturated folate body stores underwent strictly 
standardised independent study days (two to four weeks apart) in random order. 
They received, after an overnight fast, either a single oral portion of each dairy 
product, an oral dose of a pharmaceutical preparation of (6S)-5-CH3-H4folate, or 
an intra muscular injection of (6S)-5-CH3-H4folate as a reference dose. One study 
day with no folate dose application was carried out to account for baseline folate 
excretion into stomal effluent. For further details see Fig. 6 and Paper V.  
 
Methods of quantification 
Analysis of vitamin B12 and folate  
The commercial RPBA kit, SimulTRAC-SNB Radioassay Kit, Vitamin B12 [
57Co] 
/Folate[
125I] (ICN Pharmaceuticals, Orangeburg, New York, USA), was optimised 
and evaluated for analysis of vitamin B12 and folate in milk and fermented milk 
products (Papers I & II). The kit principle is based on binding of the vitamins to 
specific binding proteins included in the kit. For vitamin B12 this binding protein is 
porcine intrinsic factor, and for folate a folate-binding protein from bovine milk is 
used. Since the kit is produced for clinical samples (plasma and whole blood) a 
crucial step in vitamin analysis in foods using this method was the pre-treatment of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The human ileostomy model. 
Left: Details on administration of doses and sample collection, 1) oral administration of test 
foods or pharmaceutical folate preparations, 2) i.m. injection of folate reference dose, 3) 
blood collections over 10 h post-dose (n = 11) 4) collection of ileostomal effluent every 
second hour over 10 h post-dose, 5) urine collection over 10 h post-dose, 6) liver = storage 
organ for folate, pre-saturation prior to each test day. Right: Information on test doses, all 
test days performed for each subject randomly 2-4 weeks apart. 
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samples. Simultaneous quantification of vitamin B12 and folate from one sample 
was not possible since the sample preparation procedures prior to quantification 
differed for the vitamins.  
 
Optimisation of sample preparation and RPBA quantification of vitamin B12 and 
folate   
Optimisation of dairy sample preparation prior to vitamin B12 quantification by 
RPBA included studies on the effect of extraction buffer molarity, and cyanide 
concentration on the RPBA outcome. In addition, three levels of pancreatin were 
tested to optimise the yield of vitamin B12 from the protein-rich dairy products 
(Paper I). Regarding folate analysis using the RPBA method, the RPBA response 
for various folate compounds was investigated. Two different sources of γ-
glutamyl hydrolase were also tested (Paper II).  
 
The radioprotein-binding assay procedure was carried out according to kit 
description apart from two important exceptions; 1) use of purity controlled 
external calibrants, in the same form as the dominating derivative in the food 
sample, and 2) dilution of all samples and standards in extraction buffer instead of 
buffers provided with the kit. Checks for possible matrix effects from dairy 
samples on the kit performance were performed for each new matrix introduced 
into the RPBA. This was done by introduction of matrix blank samples (dairy 
sample without the kit vitamin-binder) to control for unspecific binding of 
substances from the dairy sample to kit material. Furthermore, the effect of 
endogenous substances was controlled by dilution of the in-house reference 
material, wpc 65, into the concentration range of the calibration curve (vitamin B12: 
100-2000 pg/ml, and folate: 0.5-10 ng/ml). Recovery tests were used to control for 
vitamin losses during the entire quantification procedure. Prior to extraction of 
dairy samples an amount corresponding to the native vitamin content was added in 
form of a purity-checked calibrant. Repeatability, both within a day and between 
days, was controlled both for sample extraction, the RPBA step, and for the entire 
quantification procedure for vitamin B12 and folate. A certified reference material, 
CRM 421, was repeatedly analysed to check the method accuracy and to enable 
comparisons with other analytical methods (Papers I & II). The selectivity of the 
kit folate-binder for different folate forms was investigated (Paper I). To perform a 
similar study for the kit vitamin B12-binder was, however, not necessary since all 
vitamin B12 derivatives were converted into the most stabile form, cyanocobalamin, 
during sample preparation.  
 
Other quantification methods used for vitamin analyses 
Results obtained with the RPBA were confirmed by analyses of the same samples 
with HPLC (only folate quantification) and microbiological assay (both vitamin 
B12 and folate) (Papers I-III).  
 
The HPLC method used for quantification of folate in milk (Paper II) included 
heat extraction of samples in phosphate buffer, pH 6.1, followed by deconjugation 
with hog kidney conjugase and purification by solid-phase extraction using strong 
anion exchange (SAX) columns (Jastrebova et al., 2003). Subsequent 
quantification of 5-CH3-H4folate, H4folate, 5-HCO-H4folate and folic acid was   39
performed using a reversed-phase HPLC method with fluorescence detection 
(290/360 nm) and UV detection (290 nm). The analytical column was a Zorbax C8 
(4.6*150 mm; 5 µm) and the mobile phase consisted of 0.03M phosphate buffer, 
pH 2.3, and acetonitrile as a gradient from 6-25%. The flow was 0.4 mL/min. 
 
Extraction of samples from the folate bioaccessibility study in vitro (Paper III) 
included heat extraction in phosphate buffer, pH 6.1, and deconjugation with 
human plasma conjugase. Affinity chromatography columns containing FBP were 
used to clean and concentrate samples prior to quantification of folic acid and 5-
CH3-H4folate. The reversed-phase HPLC method involved UV (290 nm) and 
fluorescence detection (290/360 nm), an inertsil 5 OD-3 column (3*100 mm; 5 
µm) was used, and the mobile phase consisted of 0.03M phosphate buffer, pH 2.1, 
and acetonitrile 5-80%, with a flow of 0.4mL/min (Verwei et al., 2003). 
 
Quantification of vitamin B12 and folate by microbiological assay (MA) was 
performed at the Swedish National Food Administration according to their in-
house methods (AOAC, 2000b, AOAC, 2000a). In brief, for vitamin B12 the 
sample extraction involved addition of cyanide and use of α-amylase treatment, 
followed by quantification using L. delbrueckii as assay organism and 
cyanocobalamin as calibrant. Folate analysis included tri-enzyme treatment (α-
amylase, protease and γ-glutamyl hydrolase from chicken pancreas), the 
microorganism used was L. rhamnosus and folic acid was used as calibrant.    
 
Folate concentrations in test foods, pharmaceutical folate doses, plasma samples, 
and urine and ileostomal effluent samples obtained from the human experiment 
(Paper V) were quantified by HPLC according to Jastrebova et al. (2003). The 
sample pre-treatment is described in detail by Witthöft et al. (2003). In brief, with 
the exception of plasma samples, which were only purified by SAX prior to 
quantification, it included heat extraction in phosphate buffer, pH 6, followed by 
treatment with hog kidney conjugase. All but the urine samples were purified by 
solid-phase extraction using SAX columns. The urine samples were purified by use 
of affinity chromatography columns containing FBP.  
 
The distribution of radioactively labelled folate derivatives within collected 
protein fractions after gel filtration was determined by scintillation measurements 
(Paper IV).  
 
Quantification of FBP 
FBP concentrations in samples from in vitro and in vivo studies on folate 
bioavailability (Papers III-V) were quantified using a two-site enzyme-linked 
immunosorbent assay (ELISA) developed by Høier-Madsen et al. (1986). The 
antibody against bovine milk FBP was obtained from the State Serum Institute 
(Copenhagen, Denmark) and the FBP calibrant from the Central Hospital 
(Hillerød, Denmark). The ELISA quantification procedure is described in detail by 
Wigertz et al. (1996). Briefly, to 1-3 g of sample 0.09 g of Triton X-100 was 
added. The sample was put on a shaking device, incubated for 45 min at room 
temperature and thereafter diluted to a concentration of approximately 0.4 nmol 
FBP/L and applied to a microtiter plate. An eight-point calibration curve from 
0.002-1.1 nmol FBP/L was prepared and included in each ELISA run. The in- 40
house reference material (wpc 65) was included in every analysis to control for the 
between-run variation. Whey proteins (Paper IV) were fractionated by gel filtration 
(size-exclusion chromatography using a Sephadex column) and collected fractions 
analysed for FBP using ELISA. SDS-PAGE combined with immunoblotting was 
used to confirm ELISA results from collected protein fractions.  
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Results and discussion 
 
Method optimisation  
The RPBA was evaluated as a fast, relatively easily handled, method with the 
capacity to quantify vitamin B12 and folate in large series of milk and dairy 
samples. However, for folate quantification, it must be emphasised that knowledge 
about the folate pattern within the unknown sample is crucial due to a differing 
response of the folate-binder, provided in the kit, to individual folate compounds. 
This method is thereby only suitable for quantification of folate in folate-fortified 
food products or foods in which one folate form is dominating, such as, e.g. milk, 
where 5-CH3-H4folate is the main folate form (Gregory, 1984, Holt et al., 1988, 
Vahteristo et al., 1997). The application of food matrices into a RPBA kit 
produced for clinical samples required careful optimisation of sample pre-
treatment and evaluation of kit performance due to introduction of new sample 
matrices, buffers, and calibrants. (Papers I & II). Quality control data from the 
entire procedure of vitamin B12 and folate quantification are summarised in Table 
3. These and further quality data are presented and discussed in the following 
sections.  
 
RPBA quantification of vitamin B12 (Paper I) 
Performance data from the optimised quantification procedure showed the RPBA 
method to be suitable for the determination of vitamin B12 in dairy products. The 
overall recoveries in dairy matrices ranged between 88-96%, and the coefficients 
of variation between replicates both within a day and between days were below 
7%. Also introduction of samples and external calibrants in extraction buffer did 
not affect the kit performance negatively, as seen from the calibration curve slopes 
of 0.97 ± 0.04 and linearities of > 0.995 (range 0-2000 pg/ml).  
Table 3. Performance data from sample preparation and quantification of  
vitamin B12 and folate in milk and dairy products using the optimised RPBA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 ED-50 is defined as the concentration where 50% of the binding proteins  
are occupied by tracer and the remaining 50% by vitamin from the sample 
Parameters Performance 
 Vitamin  B12 Folate 
Quantification procedure     
Recovery (%)  88-96  94-97 
Repeatability (CV%)     
   - within day  < 6  < 6 
   - between day  < 7  < 5 
CRM 421 (µg/100g DM)  2.74 ± 0.1  91 ± 5 
Kit performance     
Calibration curve range  
(vit.B12 pg/ml, folate ng/ml) 
100-2000 0.5-10 
Slope 0.97  ± 0.04  1.09 ± 0.05 
Linearity  > 0.995  > 0.995 
ED-50 
1  
(vit.B12 pg/ml, folate ng/ml) 
553 ± 15  1.85 ± 0.18 
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To test effects from introduction of a dairy matrix into the RPBA, seven dilutions 
over the concentration range of the calibration curve were performed from three 
independent replicates of wpc 65. These showed the same slopes as the calibration 
curve, and measured vitamin B12 concentrations were back calculated to 
concentrations of undiluted samples resulting in a coefficient of < 12% (Fig. 7). 
Control of non-specific binding of tracer to kit material, e.g. tube walls, was 
routinely included in the kit procedure (called kit blank). This was performed by 
addition of tracer, extraction buffer and blank reagent, to test tubes in duplicate. 
Resulting radiation, expressed as counts per minute, was automatically subtracted 
from each test tube. Non-specific binding of tracer to the food matrix was tested 
for each dairy product by addition of tracer, sample and blank reagent to test tubes 
in duplicate (called sample blank). Sample blanks from studied dairy matrices did 
not differ from kit blanks, showing no unspecific binding of endogenous 
substances within these samples to kit material other than the vitamin B12-binder.  
Analyses of CRM 421, a certified milk powder, resulted in a vitamin B12 value 
within the certified range. In comparison with results from studied dairy products 
obtained by the MA technique, RPBA results were between 6-35% lower (see 
Table 3 in Paper I). The microorganism used in the microbiological assay, L. 
delbrueckii, has been shown to respond also to vitamin B12 analogues (without 
vitamin activity) (Muhammad et al., 1993b, Herbert, 1996). The possible existence 
of such forms in dairy products may partly explain the difference in results 
obtained by the two methods. The vitamin B12-binder used in this RPBA kit is a 
purified intrinsic factor from hog, which shows less than 0.01% cross-reactivity to 
cobinamide (inactive vitamin B12 analogue). Another explanation of lower values 
obtained with RPBA might be that pancreatin treatment of some of the products 
was not carried out prior to quantification (see Table 3 in Paper I). The pancreatin 
treatment of protein-rich dairy samples needs further optimisation, but it was 
shown to substantially increase the vitamin B12 yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Comparison of a cyanocobalamin (CN-Cbl) standard curve (dilution range 100-
2000 pg/ml, 5 points) with three replicate wpc 65 (whey protein concentrate) samples 
(dilution range 100-2000 pg/ml, 7 points).  
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The RPBA method has earlier been applied for vitamin B12 analysis in foods 
(Richardson et al., 1978, Králová et al., 1982, Casey et al., 1982, Österdahl et al., 
1986, Andersson et al., 1990). Most studies conclude that the pre-treatment of food 
samples is a critical step in achieving reliable results, but few studies have 
systematically investigated effects on kit performance. Pre-treatment usually 
involves heat extraction of the food sample in a buffer, at acidic pH, containing an 
excess of cyanide, metabisulphite or nitrite to enable conversion of native vitamin 
B12 derivatives in the sample. Our optimised sample preparation of milk and 
fermented milk products included heat extraction at 121 °C for 25 min in a 0.1M 
acetate buffer (pH 4.5) containing an excess of cyanide, followed by pancreatin 
treatment (for further details see Paper I).  
 
Interestingly, the concentration of cyanide added to the sample substantially 
influenced the outcome of the RPBA used in our studies. A final concentration of 
0.08mM and 40mM cyanide was evaluated. The higher cyanide concentration 
resulted in a recovery of 121 ± 4% in cyanocobalamin spiked extraction buffer, 
whereas a recovery of 94 ± 2% was obtained with the lower cyanide concentration. 
Most previous studies use a cyanide concentration of ca 1mM (Österdahl et al., 
1986, Muhammad et al., 1993a) but a 39-fold increased concentration or even 
higher concentrations are reported as optimal in some studies (Beck, 1979, Králová 
et al., 1982, Andersson et al., 1990). We do not have an explanation of this 
overestimation of vitamin B12 content due to a high cyanide concentration. Cyanide 
is the favourable conversion substance to add to a sample prior to quantification, in 
comparison to metabisulphite and nitrite. This is because cyanide converts most 
vitamin B12 forms into (di)cyanocobalamin, whereas metabisulphite converts only 
aquacobalamin into sulphitocobalamin and nitrite converts only hydroxocobalamin 
into nitritocobalamin (Muhammad et al., 1993a, for further details see Table 1 in 
the Introduction section). The advantage of cyanide addition is, therefore, that after 
extraction only one vitamin B12 form dominates within the sample, and this form is 
used for preparation of the calibration curve in the RPBA. The problem regarding 
a varying selectivity of the vitamin B12-binder to different vitamin B12 forms is 
thereby avoided.    
 
Excessively high extraction buffer molarity also affected the RPBA result 
negatively. Application of a dairy sample extracted in 0.4M acetate buffer 
increased the maximum binding capacity of the vitamin B12-binder and, as a 
consequence, the competition conditions are altered for the isotope labelled 
vitamin B12 (tracer) and the vitamin B12 from the unknown sample for a limited 
number of vitamin B12-binding proteins. This was most probably caused by a pH 
decrease after introduction of a buffer with such high molarity. Our optimised 
preparation of dairy products prior to quantification of vitamin B12 included use of 
0.1M acetate buffer, which did not interfere with the binding capacity of the 
vitamin B12-binder.   
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RPBA quantification of folate (Papers II & III) 
In contrast to vitamin B12, the endogenous mix of folate derivatives within a food 
sample is not actively converted during sample pre-treatment prior to RPBA 
quantification. To obtain reliable results with this method, knowledge about the  
dominating folate derivative in a sample, and use of this compound as calibrant, is 
crucial. The varying responses of the folate-binder provided in the kit (bovine milk 
folate-binding protein) for different external folate calibrants, at the prevailing 
assay pH of 9.5, are presented in Fig. 8 (Paper II). At this pH, the response for 
(6R,S)-5-CH3-H4folate was approximately 15% higher than for folic acid. 
Compared with the (6R,S)-5-CH3-H4folate curve, the presence of H4folate in a 
sample would lead to a significant overestimation of the folate content, whereas the 
response for 5-HCO-H4folate was very low, making quantification by RPBA 
inappropriate for this folate form. However, no measurable response was found for 
pABG (para-aminobenzoyl-L-glutamic acid) and Pt-6-COOH (pterin-6-carboxylic 
acid), two common folate degradation products, making the RPBA suitable for 
folate retention studies during processing of foods where degradation products 
from oxidation of folate can occur. The optimised sample preparation and 
introduction of samples and external calibrants in extraction buffer into the kit did 
not affect the assay performance negatively. Performance data from assays using 
(6R,S)-5-CH3-H4folate as calibrant showed the RPBA method to be reliable for 
milk and wpc 65 (Table 3). Overall recoveries (94-97%) and coefficients of 
variation both within day and between days (< 6%), as well as the absence of dairy 
matrix effects disturbing the assay performance were demonstrated (Paper II). 
 
The optimised and evaluated RPBA was applied for folate analyses in yoghurt 
samples from studies in TIM (Paper III). Since the yoghurt products were fortified 
with either (6S)-5-CH3-H4folate or folic acid, it was obvious to use the respective 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. RPBA response to individual folate derivatives at prevailing assay pH of 9.5.  
H4folate, tetrahydrofolate; 5-CH3-H4folate, 5-methyltetrahydrofolate; PteGlu, Pteroyl-L-
monoglutamic acid; PteGlu2, Pteroyl-L-diglutamic acid; kit PteGlu, folic acid provided by 
the kit; PteGlu3, Pteroyl-L-triglutamic acid; 5-CHO-H4folate, 5-formyltetrahydrofolate. 
Concentrations are calculated against the theoretical concentrations of 5-CH3-H4folate.  
With kind permission from Strålsjö et al., Food Chemistry, 2002. 
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folate forms as calibrants in subsequent RPBA. Here we experienced for the first 
time the differing affinity of the kit binder to (6R,S)-5-CH3-H4folate and the newly 
commercially available natural diastereoisomer (6S)-5-CH3-H4folate, as studied in 
detail and reported by Strålsjö et al. (2003). The RPBA was not negatively affected 
by the TIM sample matrix as shown by inclusion of sample blanks prepared in 
jejunal and ileal dialysates and ileal delivery. Overall recoveries in jejunal and ileal 
dialysates and ileal delivery samples were from 90-102% for both folate forms. 
However, the residues from TIM, material remaining in the model compartments 
after ending the experiment (used for calculation of folate mass balances), denoted 
strong matrix effects on the RPBA, resulting in an overestimation of the folate 
content. This was probably caused by the high content of disturbing substances 
after addition of digestion enzymes and from the pH adjustment solutions. The 
variation between duplicate determinations of TIM samples was somewhat higher 
than from food samples such as milk and fermented milks. This emphasises again 
the need of careful evaluation of the assay performance when introducing a new 
matrix into the kit (Paper II).  
 
Folate concentrations obtained by RPBA were in line with results from the same 
set of samples analysed by MA (Paper II) and HPLC (Papers II & III). Using 
HPLC, selected individual folate forms are quantified. This can result in a lower 
sum of folate compared with the value of total folate obtained by RPBA. This can 
e.g. be observed in Paper III when presenting folate concentrations in folic acid-
fortified milk, where the native 5-CH3-H4folate content was not quantified by the 
HPLC method used, but by RPBA. 
 
Quantification of FBP by ELISA (Papers III-V) 
Method control for ELISA included recovery studies in assay buffer and milk, 
repeatability studies with wpc 65 (within and between assays), and analyses of 
blank samples (matrices free of FBP). FBP-spiked assay buffer and milk resulted in 
recoveries ranging from 80-110%. Coefficients of variation were <12% for six 
replicates of wpc 65 analysed within an assay, and the between assay variation 
<15% for individual wpc 65 samples quantified in separate ELISA runs (n = 20). It 
could be confirmed that, as expected due to the membrane cut-off of 5 kDa, no 
FBP was detected in TIM dialysate samples (Paper III). Results from 
quantification of stomal effluent samples must be considered as semi-quantitative 
since the extraction method used was not optimised for this matrix. However, no 
FBP was detected in stomal effluent samples from test days where no FBP were 
given (N- and U-days), proving that the matrix did not result in a false positive 
response (Paper V). An important aspect not previously reported is that the ELISA 
method does not discriminate between ‘free’ FBP and FBP in complexes with 
ligand. This was observed from studies where addition of an excess of folic acid or 
5-CH3-H4folate to the FBP calibrant, followed by preparation of calibration curves 
from the original FBP calibrant (folate free) and the folate-spiked FBP calibrants, 
resulted in almost identical calibration curves (results not shown). 
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Retention studies 
Vitamin B12 (Paper I) 
Vitamin retention studies were focused on vitamin B12. Varying contents of vitamin 
B12 and folate in different fermented dairy products may be expected due to 
disparities in manufacturing procedures. Factors such as initial heat treatment of 
the milk, composition of starter culture, separation of whey, and subsequent 
ripening periods are reported to influence the retention of these vitamins (Janicki & 
Obrusiewicz, 1970, Renner, 1983, Scott & Bishop, 1988, Andersson & Öste, 
1992a, Andersson & Öste, 1992b). To our knowledge, this is the first study to map 
vitamin B12 retention during one and the same batch and subsequent storage period 
by direct quantification of vitamin B12 in collected milk, curd, and whey samples.  
Results of the present study showed that the initial heat treatment of milk at either 
76 °C for 15 s (all cheeses) or 95 °C for 5 min (fermented milks) did not alter the 
vitamin B12 concentration in the milk. Our results are in line with a previous 
investigation (Andersson & Öste, 1992a, Andersson & Öste, 1992b), and partly 
agree with previous studies reporting the heat treatment of milk to result in a 
decrease of vitamin B12 concentrations ranging from only a few percent up to 20% 
(Renner, 1989). 
 
In the fermented milks the presence of viable starter cultures was most probably 
the major reason for the substantial (40-60%) decrease in vitamin B12 content seen 
during storage of the final product until the ‘use by date’ (14 days after packaging) 
(Fig. 9), although other degradation routes can not be ruled out. Our results support 
findings in previous studies, performed by MA, reporting a decrease in the vitamin 
B12 content after fermentation of milk with selected starter cultures (Reddy et al., 
1975, Alm, 1982, Friend et al., 1983, Rao et al., 1984).  
 
The separation of whey during production of cottage cheese, hard cheeses and 
blue cheese was the major cause of vitamin B12 losses in the final product (Figs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Retention of vitamin B12 during manufacture of fermented milks. 
Retention is calculated and expressed as percentage of vitamin B12 content in starting milk, 
which is set to 100% (first set of bars). 
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10-12). During cheese-making 16-72% of the vitamin B12 from milk was retained 
in the cheese curd, whereas the rest was found in the excluded whey. The 
concentrations of vitamin B12 found in studied hard cheeses are well in line with 
concentrations reported previously using MA (Renner, 1983, Scott & Bishop, 
1988). Mass balances of vitamin B12 from the entire manufacturing procedure of 
studied cheeses (with the exception of Herrgård
®) did not deviate substantially 
from 100%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Retention of vitamin B12 during manufacture of cottage cheese. 
Retention is calculated and expressed as percentage of vitamin B12 content in starting milk, 
which is set to 100% (first bar). The second bar represents results on distribution of vitamin 
B12 in whey and curd, after drainage following addition of starter cultures and rennet. After 
exclusion of the whey fraction, the third bar shows the retention of vitamin B12 in the rinsed 
curd together with the part of vitamin B12 originating from added dressing. The fourth bar 
shows the retention of vitamin B12 after storage of the cottage cheese until “use by date”.
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This may be interpreted as if negligible degradation of vitamin B12 occurred. 
Degradation, however, may not be completely excluded since losses might have 
been compensated for by a possible vitamin B12 synthesis by viable 
microorganisms in the starter cultures. (Paper I)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Retention of vitamin B12 during manufacture and ripening of two hard cheeses: 
Grevé
®and Herrgård
®. 
Retention is calculated and expressed as percentage of vitamin B12 content in starting milk, 
which is set to 100% (first set of bars). The second set of bars show the retention of vitamin 
B12 in the whey and curd fractions, respectively. Only the curd fraction is used in the 
following steps, where the three following sets of bars reflect the vitamin B12 retention in 
the cheeses during ripening at 6, 12 and 32 weeks, respectively. Values are corrected for 
loss of water during the ripening period. 
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Folate 
Few investigators have reported results from characterisation of folate pattern in 
fermented dairy products (Müller, 1993, Vahteristo et al., 1997, Konings et al., 
2001). They observed presence of H4folate, 5-CH3-H4folate, 5-HCO-H4folate, and 
10-HCO-H4folate in yoghurt, fermented buttermilk and cheese. It must be stressed 
regarding these results that quantification of 5-HCO-H4folate by HPLC is difficult 
due to a low sensitivity and problems with peak masking. Concentrations of 5-
HCO-H4folate are therefore easily overestimated.  
 
Due to the possible content of 5-HCO-H4folate combined with the varying 
selectivity of the kit folate-binder, we raised concerns about the reliability of the 
RPBA for quantification of natural folate concentrations in fermented dairy 
products. Folate concentrations in milk after heat treatment and in the six studied 
‘ready to consume’ products were obtained by RPBA using the racemic 
commercially available (6R,S)-5-CH3-H4folate as calibrant, and by MA (Table 4). 
Results from analyses of the same set of samples with MA confirmed the RPBA 
results. However, even if the MA is the official method for folate analysis in food 
(AOAC, 2000a), it has been reported to respond differently to various folate forms 
(Goli & Vanderslice, 1989). Natural food folate is always present in the 
biologically active diastereoisomeric form, which in the case of 5-CH3-H4folate is 
the (6S)-form. The response of the kit folate-binder to the (6S)- and the racemic 
(6R,S)-form of 5-CH3-H4folate differs by approximately 30% under the prevailing 
assay conditions at pH 9.5 (Strålsjö et al., 2003). Therefore, results from folate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Retention of vitamin B12 during manufacture and ripening of blue mould cheese, 
Kvibille ädel.  
Retention is calculated and expressed as percentage of vitamin B12 content in starting milk, 
which is set to 100% (first bar). The second set of bars show the retention of vitamin B12 in 
the whey and curd fraction, respectively. Only the curd fraction is used in the following 
steps, where the two next sets of bars reflect the vitamin B12 retention in cheese after 
packaging and at “use by date”, respectively. Values are corrected for loss of water during 
storage. 
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quantification with (6R,S)-5-CH3-H4folate as calibrant in the RPBA are 
underestimated by about 30%. With the above-mentioned limitations in mind, a 
tentative discussion on folate retention during processing follows below.  
 
Most probably, in line with findings for vitamin B12, much of the water-soluble 
folate is excluded with the whey fraction during manufacture of cheese. However, 
this can only be speculated upon since no whey fractions were analysed for folate 
in the present study. Folate retention calculations were based on the total amount of 
folate in milk and in ‘ready to consume’ products, respectively, multiplied by the 
total mass of the fraction of interest (specific data obtained during sampling from 
each manufacturing process).   
 
The folate content was doubled in Filmjölk and an increase of 40% was seen in 
Yoghurt naturell, in comparison with milk (Table 4). These results are in line with 
findings from a study in which folate concentrations were determined in fermented 
milks and in pasteurised milk (Scott & Bishop, 1986, Scott & Bishop, 1988). In the 
present context the increase of folate content found in the fermented milks was 
attributed to the starter cultures involved. A recent study performed to examine the 
ability of different lactic acid bacteria strains to synthesise or utilise folate during 
fermentation of reconstituted milk showed a 3-4-fold increase of folate after 
fermentation with L. thermophilus species, whereas fermentation using L. 
bulgaricus species resulted in only mildly elevated or even decreased folate 
concentrations (Crittenden et al., 2003). Selected strains of S. thermophilus, L. 
acidophilus, B. longum, and L. bulgaricus were found by Lin & Young (2000c) to 
synthesise substantial amounts of folate during fermentation of reconstituted milk. 
Interestingly, in that study, a decrease of folate content was observed after storage 
of the fermented milks for up to three weeks at 4 °C, suggesting utilisation of folate 
by involved lactic acid bacteria.  
 
During production of cottage cheese, rennet is added and the whey fraction is 
removed. The mass of the curd corresponded to 14% of the original milk amount. 
Table 4. Folate concentrations in milk and fermented dairy products, quantified by RPBA 
and MA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results as means ± range, n = 2. na: not analysed. 
Food RPBA 
(µg/100g) 
MA 
(µg/100g) 
Milk  5 ± 0.1  5 ± 0.2 
Fermented milks     
Filmjölk  9 ± 0.6  11 ± 1 
Yoghurt
  7 ± 0.4  10 ± 0.5 
Cottage cheese     
Keso
® 9  ± 0.3  na 
Hard cheese     
Grevé
® 16  ± 1  na 
Herrgård
® 18  ± 0.5  21 ± 0.6 
Blue cheese    
Kvibille ädel
  30 ± 2  na 
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The curd with added dressing contained about 40% of the folate content from the 
starting milk. Ten litres of milk are needed to produce 1 kg of cheese (Renner, 
1983). This was confirmed in the present study, where the amount of cheese curd 
corresponded to 10% of the total milk volume. The folate content in the hard 
cheeses, Grevé
® and Herrgård
®, were found to be ca 30% of the folate content in 
the amount of milk needed for production of these cheeses. In blue cheese, Kvibille 
ädel, approximately 67% of the milk folate content was recovered in the final 
product. Our findings of 16-18 µg folate/100g hard cheese (Table 4) were lower 
than folate concentrations reported in a wide range of retail cheeses on the UK 
market, where folate concentrations range from 24 to 44 µg folate/100g hard 
cheese (Scott & Bishop, 1988). Different cheese varieties and different analytical 
methods might explain these differing results. 
 
In the present study, it must be stressed that no direct analyses were performed to 
quantify folate in the whey fractions, and therefore it was not possible to obtain 
folate mass balances from the curd and the whey fractions. A possible synthesis or 
utilisation of folate by included starter cultures or actual degradation of folate 
during the manufacturing procedure therefore cannot be interpreted. As already 
mentioned, previous investigations report cultures and single strains of lactic acid 
bacteria to either utilize or synthesise vitamin B12 and folate.  
 
In conclusion, it would be possible to increase the vitamin content by choosing 
starter cultures or single strains of lactic acid bacteria that synthesise these 
vitamins. That folate production and utilisation in mixed bacteria cultures appear to 
be additive, as reported by Crittenden et al. (2003), would enable production of 
custom-built vitamin producing starter cultures from interesting single strains. 
Furthermore, re-introduction of whey in, e.g. cheeses could markedly enhance the 
vitamin content.  
 
FBP 
We were also interested in studying the concentrations of FBP in milk and some 
fermented dairy products, and to investigate how the effects of process conditions 
such as heat treatment affected the FBP content in milk. In milk prior to heat 
treatment, 153 nmol FBP/L (n = 2) was observed which, after heat treatment at 76 
°C for 15 s, was lowered by about 20% to 124 nmol FBP/L (n = 2). After heat 
treatment at 96 °C for 5 min, no detectable amounts of FBP were found in the milk 
(n = 2) and as a consequence no FBP was detected in the fermented milks, i.e., 
Filmjölk and Yoghurt (n > 10). These findings are in line with results reported 
previously (Wigertz et al., 1997). Nygren et al. (2003) report heat treatment of 
isolated FBP in a buffer solution (pH 7.4) at 95 °C for 5 min to reduce the initial 
FBP concentration by ca 50%. These differences in results obtained from the two 
above-mentioned studies on heat treatment of FBP can only be explained by a 
difference in the matrices in which FBP were present (milk and buffer, 
respectively). An explanation of the higher recovery of FBP in buffer might be that 
FBP are reported to form clusters in a buffer environment (Salter et al., 1981), and 
might thereby have been less vulnerable to heat denaturation, compared with FBP 
in milk, in which it is reported to appear mainly in monomeric form (Salter et al., 
1981). Another circumstance that could explain part of the difference is the fact  52
that the ‘buffer matrix study’ was performed in lab scale while the ‘milk matrix 
study’ was performed in commercial scale. 
 
In the hard cheeses (milk heat-treated at 76 °C for 15 s), Herrgård
® and Grevé
®, 
22 and 25 nmol FBP/kg, respectively, were observed. This is somewhat higher, but 
in line with, FBP levels in hard cheeses presented previously (Wigertz et al., 
1997a). Since FBP is a whey protein, it is not surprising to find only a small part of 
the FBP in cheese. Taking into account that about 10 litres of milk (with a 
concentration of about 140 nmol FBP/L) are needed to produce 1 kg of cheese 
(Renner 1983), it can be concluded that less than 2% of the FBP from milk was 
recovered in hard cheese. In hard cheese, FBP and folate were found in a 1:15 
relationship on a molar basis. This result suggests that the dominant fraction of 
folate in cheese exists ‘free’ (not bound to FBP). However, binding of folate to 
other proteins in cheese cannot be ruled out.  
 
Impact of FBP on folate bioavailability  
Binding characteristics and stability of FBP - in vitro studies (Paper IV) 
Our static in vitro studies on binding of a mixture of (6R,S)-5-CH3-H4folate and 
folic acid to FBP showed a higher affinity for folic acid compared with (6R,S)-5-
CH3-H4folate at pH 7. The pH-dependency of FBP affinity for different folate 
compounds has been reported in many previous studies (Givas & Gutcho, 1975, 
Longo & Herbert, 1976, Salter et al., 1981, Holm & Hansen, 2001), and was 
confirmed in the present study.  
 
From static experiments investigating the folate-binding to FBP (folic acid and 
5-CH3-H4folate individually studied) after pepsin digestion, we observed a striking 
difference between folic acid and (6R,S)-5-CH3-H4folate. At pH 7, about 80% of 
both folate derivatives was found bound to FBP. No difference in extent of binding 
was observed after pH adjustment to pH 3. However, after incubation with pepsin 
for 1 h the fraction of FBP-bound 5-CH3-H4folate was decreased to 27%, whereas 
the fraction of FBP-bound folic acid remained unchanged.  
 
This phenomenon of different binding characteristics was further investigated in 
the dynamic in vitro model. The results from the static experiments were supported 
in the dynamic experiments, which showed folic acid to exist mainly protein-bound 
in the duodenal lumen (pH 6.5) after gastric passage, whereas the major part of 
(6R,S)-5-CH3-H4folate appeared free (Paper IV). Initially, before gastric passage, 
about 80% of both folate forms were protein-bound. The fraction of protein-bound 
folic acid was also about 80% after gastric and duodenal passage, whereas the 
fraction of protein-bound 5-CH3-H4folate decreased from 79 to 5% (Fig. 13), 
followed by a corresponding increase in the free fraction from 7 to 93%. Our 
results from folic acid-fortified whey are in line with a study performed on rats 
showing that the dissociation of folic acid and FBP in the stomach is completely    53
reversible, also after pepsin treatment (Tani et al., 1983). However, our results 
contrast with those observed in an early in vitro study (Ford, 1974) in which half of 
the folic acid-binding capacity was lost during pepsin treatment. Alterations in the 
binding characteristics to FBP for 5-CH3-H4folate were associated with pepsin 
digestion of FBP in the stomach, and we speculate that a difference in ligand 
binding of FBP for the folate forms studied was the reason. This is indirectly 
supported by Holm et al. (2001b) who suggest that individual folate compounds 
differ in their ability to induce conformational changes in bovine milk FBP when 
bound to the protein.  
 
It must be stressed that in these studies (Paper IV), the racemic mixture of 
(6R,S)-5-CH3-H4folate was used, as radio labelled (6S)-5-CH3-H4folate was not 
commercially available. The binding affinity of (6R,S)-5-CH3-H4folate to FBP at 
pH 7 is reported to be 84% of the affinity of the natural diastereoisomer (6S)-5-
CH3-H4folate (Freisleben et al., 2003).  
 
About 70% of the initial FBP content was recovered after gastric and duodenal 
passage from both (6R,S)-5-CH3-H4folate- and folic acid-fortified whey (Paper 
IV). In contrast, after passage through the stomach and the entire small intestine, 
the stability of FBP in yoghurt was observed to be dependent on folate form used 
for fortification of the yoghurt (17% versus 34% FBP stability in (6S)-5-CH3-
H4folate- or folic acid-fortified yoghurt, respectively) (Paper III). Corresponding 
FBP stability figures after gastrointestinal passage of pasteurised milk were 0-1% 
and 13%, respectively (Verwei et al., 2003). A decreased stability of FBP was seen 
after passage through the entire small intestine, in comparison with gastric and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Percentage of FBP-bound 5-CH3-H4folate and folic acid, respectively, in a 
whey solution at pH 7 before gastric passage (at t = 0 min), and collected in duodenum 
(in 30 min intervals) after gastric passage in vitro. 
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duodenal passage, which may probably be attributed to progressing digestion of 
FBP by pancreatic enzymes secreted into the jejunum and ileum.  
 
Folate bioaccessibility - in vitro studies (Paper III) 
Few studies have been performed to evaluate biological effects and bioavailability 
of biologically active (6S)-5-CH3-H4folate, which only recently became 
commercially available. Venn et al. (2003) compare low-dose supplementation of 
(6S)-5-CH3-H4folate and folic acid, and show (6S)-5-CH3-H4folate to be equally 
efficient to folic acid in lowering homocysteine concentrations in healthy persons. 
In another recent study (Venn et al., 2002), supplementation with (6S)-5-CH3-
H4folate or folic acid is reported to increase blood folate concentrations to a similar 
extent in women of childbearing age. In a study comparing the homocysteine 
lowering effect of folic acid and racemic (6R,S)-5-CH3-H4folate, it was observed 
that a dose of 400 µg folic acid/d more effectively decreases homocysteine levels 
than a dose of 480 µg (6R,S)-5-CH3-H4folate/d (Fohr et al., 2002). This might be 
explained by the use of the racemic mixture of 5-CH3-H4folate, which only 
contains half of the dose in form of the biologically active diastereoisomer (6S)-5-
CH3-H4folate. 
 
The present work is the first to present data on bioaccessibility and 
bioavailability of the natural diastereoisomer (6S)-5-CH3-H4folate from fortified 
dairy products. Bioaccessible folate is defined as the fraction of folate available for 
absorption using this model, i.e., the amount of folate released from the food 
matrix and thereby capable of passing the membranes (molecular cut-off of 5 kDa) 
in jejunum and ileum during gastrointestinal passage.  
 
Results from our TIM studies on folate bioaccessibility from yoghurt and 
pasteurised milk fortified with either the natural diastereoisomer (6S)-5-CH3-
H4folate or folic acid, with and without addition of FBP in equimolar amounts, are 
compiled in Table 5 (Paper III). Between 70 and 80% of the folate was found to be 
bioaccessible from both fortified yoghurt and pasteurised milk. After addition of 
FBP to yoghurt, folate bioaccessibility was decreased, with a more pronounced 
decrease in folic acid-fortified yoghurt compared with yoghurt fortified with (6S)-
5-CH3-H4folate (34 and 57% bioaccessibility, respectively). In contrast, FBP in 
pasteurised milk did not affect the bioaccessibility of (6S)-5-CH3-H4folate, whereas 
the bioaccessible fraction of folic acid was decreased by FBP. 
 
To summarise in vitro studies, both differences in the effect of FBP on 5-CH3-
H4folate and folic acid bioaccessibility and differences in the stability of FBP were 
most probably caused by the fact that 5-CH3-H4folate and FBP to a greater extent 
dissociate in the small intestinal lumen (pH 6.5), whereas the major part of folic 
acid appeared to be bound to FBP. These differences in binding characteristics of 
FBP might influence the bioavailability of the studied folate forms, and should 
therefore be considered when discussing the appropriateness of folate forms used 
for food fortification purposes. The greater stability of the FBP-ligand complex 
compared with ‘free’ FBP, as previously reported (Kaarsholm et al., 1993, Holm & 
Hansen, 2001), explains our results showing better FBP stability in folic acid-
fortified milk products than in milk products fortified with (6S)-5-CH3-H4folate,   55
since the major part of FBP in the latter product appear to exist without ligand 
bound during intestinal passage.  
 
The impact of bovine milk FBP on folate bioavailability seems to be affected by 
the food constituents present. Jones et al. (2003) report from a study on rats that 
the effect of FBP on folate bioavailability is greatly influenced by the presence of 
certain dietary components. Whereas presence of soluble casein and whey proteins 
increase folate bioavailability, acid-precipitated casein and a lipid-enriched whey 
preparation decrease it, as studied in rats.  
 
Folate bioavailability – human in vivo study (Paper V) 
Our study is the first to report results about the fate of FBP during gastrointestinal 
passage in humans. Interestingly, FBP was also in vivo observed to partly endure 
gastrointestinal passage, as seen from presence of FBP in ileostomal effluents. For 
all nine subjects, a significantly higher excretion of FBP into ileostomal effluents 
was observed after consumption of FBP-fortified pasteurised milk (3-43%) in 
comparison with FBP-fortified fermented milk (0-32%). This is contradictory to 
our in vitro studies in which a larger amount of FBP was observed excreted after 
gastrointestinal passage of yoghurt compared with pasteurised milk. In the TIM 
studies, however, the same protocol in regard to pH curves, gastric emptying, 
enzyme excretion, etc. was used for milk and yoghurt, whereas during digestion of 
milk and fermented milk in humans a difference in, e.g. gastric emptying, is 
reported, showing a slower gastric emptying for fermented milk in comparison with 
pasteurised milk (Strandhagen et al., 1994). We speculate that the higher FBP 
stability found in pasteurised milk might be caused by decreased exposure to 
degradation by pepsin compared with the fermented milk that remains for a longer 
period of time in the stomach.   
 
A significantly higher excretion of 5-CH3-H4folate was observed after 
consumption of all dairy products compared with basal excretion (N-day). After 
Table 5. Folate content in jejunal and ileal dialysates (absorbable fraction) and ileal 
delivery (non-absorbable fraction) after in vitro gastrointestinal passage of yoghurt and 
pasteurised milk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results as means ± range, n = 2. 
Dairy product  Jejunal 
dialysate 
Ileal 
dialysate 
Jejunal + 
Ileal 
dialysate 
(absorbable 
fraction) 
Ileal 
delivery 
(non-
absorbable 
fraction) 
  % of folate content in test food 
Yoghurt + 5-CH3-H4folate  58 ± 4  24 ± 4  83 ± 9  9 ± 1 
Yoghurt + 5-CH3-H4folate + FBP  42 ± 3  14 ± 0  56 ± 3  47 ± 5 
Yoghurt + folic acid  62 ± 2  20 ± 3  82 ± 6  6 ± 1 
Yoghurt + folic acid + FBP  25 ± 1  10 ± 2  34 ± 3  57 ± 3 
Milk + 5-CH3-H4folate  52 ± 4  25 ± 6  77 ± 9  6 ± 1 
Milk + 5-CH3-H4folate + FBP  64 ± 5  27 ± 3  91 ± 9  11 ± 2 
Milk + folic acid  47 ± 4  22 ± 2  70 ± 6  13 ± 1 
Milk + folic acid + FBP  46 ± 1  15 ± 1  61 ± 2  28 ± 7 
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consumption of pasteurised milk fortified with FBP a significantly higher folate 
excretion was found than after consumption of fermented milks, both with and 
without FBP added. No difference in folate excretion was, however, seen after 
consumption of fermented milk with or without FBP, respectively. This might 
indicate that a larger fraction of folate appears protein bound at sites of absorption 
from pasteurised milk in comparison with fermented milk. 
 
To assess relative folate bioavailability, AUCs of 5-CH3-H4folate from test 
products were compared with the AUC of the reference dose (folate injection). For 
seven out of nine subjects, a larger AUC was found after consumption of fermented 
milk without FBP in comparison with both pasteurised milk and fermented milk 
with FBP added. Thus, as indicated in the in vitro model, it was supported in the 
human study that FBP decreases the absorption of folate in milk products. In 
addition, no clear trend in folate absorption in vivo was observed comparing 
pasteurised milk and fermented milk that both had been fortified with FBP. 
 
As reported in a recent ileostomy study on folate bioavailability from spinach 
(Konings et al., 2002), high inter-individual variation in absorption and excretion 
between subjects were also observed in the present human study. However, it must 
be stressed that our study design enabled every subject to be its own control, i.e. all 
subjects ingested all test products randomly, and the absorption and excretion 
responses were compared to an injected folate dose. Furthermore, the basal 
excretion and plasma response were also identified for all individuals. The use of 
an injected folate dose as reference dose results in lower figures on folate 
bioavailability compared with an oral reference dose, which is the most commonly 
used form of reference (Prinz-Langenohl et al., 1999, Konings et al., 2002). 
However, the assumption of complete absorption of an oral reference dose might 
not be correct, whereas after an injection the entire dose is, of course, placed inside 
the body. It became obvious from collected ileostomal effluents (every second 
hour) that subjects could be grouped into slow and quick digesters, respectively. 
As a result, possible underestimation of ileostomal folate excretion in the group of 
slow digesters might have occurred, since some subjects still excreted notable 
amounts of 5-CH3-H4folate in the last fraction collected (8-10 h post-dose).  
 
To summarise the folate bioavailability studies, we observed FBP to partly 
endure gastrointestinal passage, and moreover, showed that FBP decreased folate 
bioaccessibility and absorption, both in a dynamic in vitro model and as studied in 
humans. The TIM model also revealed differences in bioaccessibility of (6S)-5-
CH3-H4folate and folic acid, which remains to be confirmed in human studies. 
Trends regarding folate bioavailability and FBP stability were the same both in 
vitro and in vivo, which suggests TIM to be a potential model for prediction of 
folate bioavailability. However, quantitative data on, e.g. amounts of folate 
absorbed or bioaccessible, and the extent of folate excretion, were differing 
between the two models. These differences can be explained by a number of 
factors. As mentioned previously, the same TIM protocol, regarding e.g. gastric 
passage time, pH curves, and enzyme ‘secretion’, was used for both pasteurised 
and fermented milk in the in vitro model, whereas in the human model the 
physiological differences during digestion of pasteurised and fermented milk, e.g. 
regarding gastric passage time, are prevailing. In addition, the in vitro experiments   57
were conducted over a time period of five hours, whereas in the human study the 
experimental period continued for ten hours. Moreover, a large inter-individual 
variation was observed in the human study. Use of the TIM model provides strictly 
standardised conditions, which make a direct comparison between, e.g. dairy 
matrices, easier than in human studies. However, the question of how well results 
obtained in a strictly standardised model can be translated into general dietary 
recommendations given to a population of individuals still remains. We conclude 
that both models are suitable for studies of food matrix effects on folate 
bioavailability. None of them provides any exact figures of the actual folate 
bioavailability and, instead, only general conclusions about folate bioavailability 
can be drawn. 
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General discussion and conclusions 
 
One of the major aims of the present study was to investigate the nutritional role of 
bovine milk FBP regarding folate bioavailability in humans. Ever since the milk 
FBP was first reported by Ghitis (1969) there have been speculations about their 
role. Studies performed during recent decades to demonstrate effects of FBP on 
folate bioavailability have given inconsistent results; most probably many of these 
studies have suffered from lack of specific and validated methods. In addition, 
most studies were performed using animal models (Salter & Mowlem, 1983, Tani 
et al., 1983, Tani & Iwai, 1984, Swiatlo et al., 1990, Jones et al., 2003).  
 
By comparing the in vitro TIM model with a study using human ileostomists, we 
could demonstrate partial survival of FBP during gastrointestinal passage using a 
selective ELISA method for analysis of FBP. This was accompanied by a lower 
bioaccessibility of folate, more pronounced for folic acid than for 5-CH3-H4folate, 
as observed in vitro. A major portion of folic acid was bound to FBP, whereas 5-
CH3-H4folate existed mainly unbound in the duodenal lumen. Using the human 
ileostomy model, only the impact of FBP on the bioavailability of 5-CH3-H4folate 
was studied, and was found to be reduced.    
 
Which conclusions regarding nutritional significance of FBP can be drawn from 
these results? Firstly, we have studied the role of FBP in an adult situation. For 
infants, a much higher survival of FBP could be expected due to a less matured 
gastrointestinal system, e.g. the gastric pH is higher and an infant’s intestinal 
mucosa is more permeable. This addresses a question for further elucidation, 
whether there exist ileal receptors for the FBP:folate complex, as suggested by 
some investigators (Salter & Mowlem, 1983), and if so, are these receptors specific 
for human milk FBP only, or also for bovine milk FBP? Future studies on infants 
are warranted, as FBP forms stable complexes with folic acid (as seen in in vitro 
studies). Most of the infant formulas and gruels are fortified with folic acid, and 
they are nowadays gently processed. Therefore, active FBP might still be present, 
impairing folate bioavailability. 
 
The infant situation is probably the most important aspect to consider in view of 
our results. For the rest of the population, the negative impact of FBP on folate 
bioavailability from a mixed diet is probably negligible, since the FBP intake 
(deriving from dairy products only), is estimated to correspond to less than 10% of 
the total folate intake. As the whey fraction is rich in FBP, it should not be added 
as an ingredient to folate-fortified foods for technological reasons. Dairy products 
can be considered as interesting folate vehicles for fortification purposes, with the 
precondition that no FBP is added, since our in vitro studies showed both folic acid 
and 5-CH3-H4folate to be highly bioaccessible in pasteurised and fermented milk.  
 
An important objective in this thesis was also to develop optimised and 
evaluated analytical methods for quantification of folate and vitamin B12 in dairy 
products, which complement the laborious and less reliable microbiological 
methods. We focussed on the sensitive and specific RPBA method. Regarding 
RPBA quantification of folate, it must be emphasised that this method is only 
reliable in those dairy samples that contain mainly 5-CH3-H4folate. For   59
quantification of vitamin B12 in dairy products, we consider the optimised RPBA 
more suitable than the official MA method. This method was developed for 
quantification of vitamin B12 in pharmaceutical preparations (2000b) and, 
therefore, use of cyanide is not considered. However, in food analysis, the 
importance of cyanide for converting vitamin B12 derivatives prior to both RPBA 
and MA quantification cannot be stressed enough. The official AOAC method is 
therefore not reliable for quantification of the vitamin in matrices containing a 
variety of vitamin derivatives. Furthermore, the cross-reactivity of the RPBA 
method to biologically inactive vitamin B12 analogues is only 0.02%, whereas the 
test organism used in the MA is reported to respond also to such analogues to a 
certain extent (Herbert, 1996). However, prior to application of the RPBA for 
quantification in other food products, it is crucial to carefully control for possible 
interfering effects from the matrix. 
 
Nonetheless, there is still a need to characterise individual forms of both vitamin 
B12 and folate in food products. Knowledge of the vitamin pattern enables us to 
critically judge different products regarding vitamin stability and bioavailability. 
Information on absorption of these vitamins from dairy products is also scanty. 
Since half of the population will suffer from folate and vitamin B12 deficiency 
during their last period of life (Hultdin, 2003) it is interesting to study the effect of 
not only absorption but also to identify food constituents that have a positive effect 
on vitamin absorption. The prevalence of Helicobacter pylori infection is common 
among the elderly. This infection causes decreased acidity in the stomach, which 
results in impaired absorption of vitamin B12 (Carmel et al., 1994). Dairy products 
have already been recognised as promising probiotics for the treatment of certain 
intestinal disorders (Dunne & Shanahan, 2002). Dairy products also provide these 
two vitamins.  
 
This project provided information to further our understanding of the nutritional 
role of bovine milk FBP and new insights on the potential fortification of dairy 
products with either folic acid or 5-CH3-H4folate. In addition, the outcome of this 
work contributed with new knowledge of the content and retention of vitamin B12 
and folate during production of fermented dairy products. Also the optimised 
RPBA methods were proven suitable for vitamin analysis in milk and dairy 
products.  
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